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Chapter 1 – Thesis Portfolio Abstracts 
Thesis Portfolio Abstract 
 
Background 
Whilst the role of Psychological Flexibility on psychosocial outcomes has been 
assessed in some chronic health conditions and cancers, its role in psychosocial 
outcomes in men with prostate cancer has not been established. Fear of cancer 
recurrence has been shown to be associated with poorer psychosocial outcomes. 
The relationship of Psychological Flexibility on the impact of fear of cancer 
recurrence has not be evaluated. Research into the measurement of Psychological 
Flexibility in individuals with chronic ill health has not revealed a definitive measure.  
 
Methods 
A systematic review of the reliability and validity of measures of Psychological 
Flexibility in individuals with chronic health conditions was conducted. A quality 
assessment of the included studies was conducted and relevant results were 
synthesised. A cross-sectional study utilising a survey methodology was conducted 
to establish the role of Psychological Flexibility and fear of cancer recurrence in 
psychological distress and quality of life in men with prostate cancer. Regression 
analyses were used to establish whether fear of cancer recurrence or Psychological 
Flexibility significantly predicted any variance in distress or quality of life. Whether 
Psychological Flexibility mediated or moderated the relationship between fear of 
cancer recurrence and psychosocial outcomes was assessed with conditional 





The systematic review revealed no single definitive measure of Psychological 
Flexibility, and that many measures currently in use within research and clinical 
settings have not been fully validated in individuals with chronic ill health conditions. 
The cross-sectional study found that Psychological Flexibility and fear of cancer 
recurrence each significantly predict variance in psychological distress and quality of 
life. Psychological Flexibility mediated and moderated the relationship between fear 
of cancer recurrence and psychological distress and mediated the relationship 
between fear of cancer recurrence and quality of life. 
 
Conclusions 
In the absence of a definitive measure of Psychological Flexibility, information on 
the measures identified were provided to allow clinicians and researchers to choose 
the most appropriate measure for their use. Future research might focus on further 
validation of existing measures of Psychological Flexibility rather than the 
development of additional measures. The challenges underlying using a 
psychometric approach to measure contextual science concepts was discussed. Due 
to the role of Psychological Flexibility within psychosocial outcomes in prostate 
cancer, it was suggested as a potential treatment target. The relevance of 
treatments such as Acceptance and Commitment Therapy, which aim to increase 
Psychological Flexibility, for men with prostate cancer was discussed. Future 
research avenues to further assess the role of Psychological Flexibility in 




Thesis Portfolio Lay Summary 
Psychological Flexibility includes things like how well a person copes and adapts to 
different psychological demands, shifts their perspective depending on their 
situation, and balances competing demands on them. Individuals who report higher 
Psychological Flexibility also report higher quality of life, lower psychological distress 
and greater overall wellbeing. Psychological Flexibility is often measured with 
questionnaires. We do not know which of these questionnaires is the most 
appropriate one to use. The scientific literature was investigated to assess what 
tools for measuring Psychological Flexibility already exist, and how well validated 
(how well assessed) they are. This identified that there is not one tool that can be 
recommended to measure Psychological Flexibility. Future research could look at 
assessing the existing tools more fully rather than trying to develop new measures.  
 
Having a diagnosis of prostate cancer can be linked with lower quality of life and 
higher psychological distress. Men with prostate cancer can also fear that the cancer 
will come back now or in the future. In other types of health conditions, higher 
levels of Psychological Flexibility have been shown to be linked with higher levels of 
quality of life and lower levels of psychological distress. The role of Psychological 
Flexibility on these outcomes in men with prostate cancer has not been established. 
This study showed that Psychological Flexibility and fear of cancer recurrence 
explain some of the differences found in quality of life and psychological distress in 
different men with prostate cancer. Psychological Flexibility also explains some of 
the relationship between fear of cancer recurrence and outcomes such as distress 
and quality of life. Psychological Flexibility may also act as a protective factor 
against the negative impact of fear of cancer recurrence.  
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Chapter 2 – Systematic Review 
Title Page 
The Measurement of Psychological Flexibility and its Component 
Parts in Chronic Health Conditions – A Systematic Review 
Written according to guidelines for Assessment (see Appendix 2.A) 
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Psychological Flexibility/Inflexibility has been shown to be related to quality of life, 
psychological distress and other important outcomes in individuals with chronic 
health conditions. There is currently no consensus on the measures of Psychological 
Flexibility/Inflexibility that should be used. Studies that assessed the reliability and 
validity of psychometric measures of Psychological Flexibility/Inflexibility in chronic 
ill health populations were reviewed. No definitive measure of Psychological 
Flexibility /Inflexibility was identified, and few measures had their reliability and 
validity completely established. Criteria to aid clinicians and researchers in choosing 
a measure are presented. Key challenges regarding the application of psychometric 














Psychological Flexibility is an important part of psychological health and is defined 
by Kashdan (2010) as how well a person copes and adapts to varying psychological 
demands, applies mental resources flexibly, shifts their perspective depending on 
their context, and how well they balance competing demands on them. It is also 
proposed that the elements of Psychological Flexibility have opposing counterparts 
which, taken together, are described as Psychological Inflexibility. Kashdan (2010) 
describes this as encompassing the other extreme of those elements of 
Psychological Flexibility and is characterised by an individual who is rigid, lacks 
sensitivity to context, and is inflexible in their thinking.  
 
Psychological Flexibility/Inflexibility underlies the therapeutic modality “Acceptance 
and Commitment Therapy” (Hayes et al., 1999) which proposes that this model of 
human behaviour consists of twelve core processes that are all interlinked. It is 
proposed that individually, six of these processes are related and together form the 
overall construct of “Psychological Flexibility” (often conceptualised as a hexaflex, 
see Figure 2.1). These six processes are said to be one side of the coin, each having 
their own counterpart, which together form “Psychological Inflexibility” (Figure 2.1) 
(Hayes et al., 2006). ACT theorises that individuals who are more psychologically 






Figure 2.1 – The Acceptance and Commitment Therapy (ACT) model of 
psychopathology (also known as the ACT hexaflex), two sides of the coin, adapted 
from Luoma et al. (2007). 
 
Psychological Flexibility as a model of human behaviour has developed from other 
behavioural theories that underlie psychological ill health. In a paper by Hayes et al. 
(1996) experiential avoidance was discussed, describing it as a process of not being 
willing to stay in contact with unpleasant private experiences, and attempts by an 
individual to change these experiences or avoid the contexts that prompt these 
experiences. This concept is an extension of the idea of avoidance of private 
experiences which is found in many psychological theories such as repression in 
Freudian theories or avoidance in Foa’s behavioural theories (Hayes et al., 1996). 
This theory of experiential avoidance was built on and became part of the 
Psychological Flexibility model (Hayes et al., 2006). More recently, several authors 
have suggested changes to the way the model of Psychological Flexibility is 
conceptualised in addition to the six processes and the unified element of 
Psychological Flexibility. Some authors suggest that Psychological Flexibility can be 
thought of as two broader processes. Firstly “acceptance and mindfulness 
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processes” and secondly “commitment and behaviour change processes” (Hayes et 
al., 2010) (see Figure 2.2). Other authors have suggested that the model can be 
thought of as involving three broad response styles, which are labelled open, aware 
and engaged (Hayes et al., 2010) (Figure 2.3).  
 
 
 Figure 2.2 – Diagram of Psychological Flexibility highlighting two potential 
overarching processes; ‘acceptance and mindfulness processes’ (dashed line box) 
and ‘commitment and behaviour change processes’ (solid line box). Note being 
present and self as context are conceptualised as falling under both types of 





Figure 2.3 – Model of Psychological Flexibility with overlays demonstrating three 
potential response styles. 
 
Regardless of how Psychological Flexibility is conceptualised, research shows 
associations with increased QoL, lower psychological distress and greater wellbeing 
(Kashdan & Rottenberg, 2010). This finding has been replicated in clinical health 
populations (McCracken & Velleman, 2010) and authors have found that 
Psychological Flexibility explains variance in impairment over and above that which 
is already explained by other established variables such as anxiety, depression, 
stress or neuroticism (Gloster et al., 2011), highlighting the importance of this 
process in explaining individual differences in mental health. 
 
Our knowledge of human suffering is always expanding and this creates a need for 
new, valid and reliable measures of psychological constructs (Boyle et al., 2015). 
Systematic reviews of measures often show a diversity across literature of the 
16 
 
reliability and validity of these measures, whether it is due to the population under 
investigation, differences in application or individuals’ differences (e.g. Bjelland et 
al., 2002). Whilst Boyle et al. (2015) suggest that better measures are needed, they 
also highlight the associated difficulty with the increasing number of measures 
causing difficulty for researchers and clinicians to be able to effectively discern what 
measures are most appropriate. Boyle et al. (2015) also suggest that when 
evaluating measures of psychological constructs not only should reliability and 
validity of these measures be assessed, but also practical elements such as cost, 
ease of use and length of scale. 
 
Within a functional contextual framework, describing the model in different ways 
(e.g. as one process, as three processes, as six processes) is not problematic, as 
within this perspective, the words or concepts are adapted to the needs of the 
context, rather than being used to represent a specific concrete concept. However, 
this does have implications for the development of measures of this construct, 
particularly as the development of measures is often based within an elemental 
realism framework (e.g. Pepper, 1942). Within this framework, concepts to be 
measured are assumed to be concrete and exist in an objective reality, separate 
from the observer. It is then the role of the researcher to be able to attempt to best 
quantify this concept, often with the use of psychometric measures, which are often 
assessed in terms of how well that measure is assessing that specific, concrete 
concept. However, the functional contextual view would be that concepts to be 
assessed are not concrete and external to us, but that the way we view concepts 
and how we measure them will in itself change that concept under investigation. 
This results in a challenge for researchers assessing Psychological Flexibility or 
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interventions that aim to change this concept. To assess change and make an 
argument for the usefulness of these concepts, we need to be able to measure 
them in some way. Traditional methods of measurement tend to be psychometric 
assessment, and therefore, psychometric measures are developed to assess 
Psychological Flexibility in a concrete way. As described, this can result in difficulties 
in regards to this fluid concept. Farhall et al. (2013) recognised that developing valid 
measures of third wave constructs is a challenge due to the differences in the 
literature regarding whether elements of the ACT hexaflex should be evaluated 
individually or whether overarching concepts such as Psychological 
Flexibility/Inflexibility should be assessed. There are different opinions in the 
literature regarding the measure of Psychological Flexibility/Inflexibility with Rolffs et 
al. (2016) suggesting that as Psychological Flexibility/Inflexibility in theory covers 
twelve processes and that all of these should be considered when evaluating this 
construct. However, other authors have recognised the fluid nature of this construct 
and that the model is still developing (Francis et al., 2016). 
 
There are many diverse measures of third wave constructs. These include global 
measures of Psychological Flexibility/Inflexibility, measures of elements of the 
hexaflex and measures that are designed for specific populations. The Acceptance 
and Action Questionnaire (AAQ-II; Bond et al., 2011) is the most often used 
measure of Psychological Inflexibility. Some authors have argued that the AAQ-II 
does not measure all facets of Psychological Flexibility, instead only measuring some 
of the twelve processes that make up the ACT model (Figure 2.1) (Wolgast, 2014). 
Indeed, even in the original validation paper by Bond et al. (2011) the AAQ-II is 
described variably as measuring acceptance, experiential avoidance and 
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Psychological Inflexibility. Studies looking at the factor structure of the AAQ-II 
appear to reveal that this measures a unified process supporting it as a measure of 
Psychological Flexibility rather than of acceptance/experiential avoidance (Wolgast, 
2014). However, recent research has suggested that perhaps this unified concept is 
not Psychological Flexibility but that the AAQ-II is actually measuring a broader 
concept like neuroticism (Rochefort et al., 2017). It is sometimes difficult to discern 
how global measures of Psychological Flexibility such as the AAQ-II link to, and are 
explicitly measuring, each of the elements of the hexaflex (Rolffs et al., 2016). 
Other authors suggest that by attempting to measure each element of the hexaflex 
in isolation a sense of the global concept of Psychological Flexibility can be lost 
(Francis et al., 2016).  
 
Farhall et al. (2013) propose that measures of these third wave constructs might 
need to be population specific. Wolgast (2014) suggest that further measures of 
Psychological Flexibility need to be identified that are contextually appropriate – for 
example, those that are validated in a specific population. The use of ACT within ill 
health populations is well-established with the American Psychological Association 
recognising it as an evidenced-based treatment for chronic pain (Hayes et al., 
2012). This has led to some measures that are not necessarily validated in an ill 
health population being used to investigate change in interventions for this 








Psychological Flexibility is being increasingly researched as part of the growing 
evidence base for ACT, particularly in chronic ill health populations. This research 
often relies on the AAQ-II (Bond et al., 2011), despite this measure not being 
validated specifically in a clinical health population. Recently, authors have also 
questioned the validity of the AAQ-II, suggesting that it is perhaps measuring a 
broader concept than Psychological Flexibility (Rochefort et al., 2017). Newer 
measures of Psychological Flexibility are being developed (e.g. Rolffs et al., 2016; 
Francis et al., 2016), which adds to the number of available measures without 
resolving which measures are valid for use in which populations. Therefore, this 
review will attempt to clarify what measures of Psychological Flexibility are available 
and valid. As some authors suggest that measures need to evaluated in line with 
their use in a specific population (e.g. Farhall et al., 2013) this review will focus on 
papers that are investigating the reliability and validity of measures for use in a 
chronic ill health population. 
The key questions that this review hopes to address are: 
1. What measures of psychological flexibility have been validated in a chronic ill 
health population? 




The review was conducted using an a priori defined protocol that was published on 
the Prospero website (Protocol Number: CRD42017056033; 
www.crd.york.ac.uk/PROSPERO/display_record.php?RecordID=56033). The protocol 
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was adapted to widen the remit of the review and this change is also recorded on 
the website. This change was undertaken as during the initial search it became clear 
that to limit to measures that assessed Psychological Flexibility in its entirety would 
not be possible because some assessment measures were claimed to measure all of 
Psychological Flexibility in one paper, but only sections in another. This lack of 
clarity in the definition of Psychological Flexibility used by some authors led to the 
change in protocol. 
 
Search Strategy 
The following databases were searched; PsychINFO, Medline, Psychological and 
Behavioural Science Collection, CINAHL Plus and the Cochrane Central Register of 
Controlled Trials (CENTRAL). In order to include any relevant papers that were not 
identified in the initial search strategy, further to interrogating these databases, 
additional searches were conducted. The reference lists of relevant systematic 
reviews that were identified in this search were examined to identify further possible 
papers. Measures of Psychological Flexibility that were identified from this search 
were investigated to identify the original paper, and then citations from this paper 
were searched for any additional relevant papers. Any researchers that were first 
authors on more than one relevant paper identified through the original search 
strategy were emailed to request any relevant unpublished data that they may have 
that could be included in the review. The first authors for the original papers of 
relevant measures were also emailed to request any unpublished work related to 
the reliability and validity of those measures specifically. Finally, a Google Scholar 
search was performed and the first ten pages (i.e. the top 100 results) were 
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interrogated for further articles not already identified. The search criteria and 
keywords used for each database can be found in supplementary file S2.1. 
 
Inclusions/Exclusion Criteria 
1. Types of study – only primary research papers were included. Books, book 
chapters, book reviews and reviews were all excluded. 
2. Assessing the reliability and validity of a tool that aims to measure an element of 
Psychological Flexibility as defined originally by Hayes et al. (2006) and 
described in Luoma et al. (2007) – Papers that assessed the reliability or validity 
of a measure that aimed to assess any aspect of the Psychological Flexibility 
hexaflex as described in Luoma et al. (2007) were included. Papers that did not 
assess the reliability or validity of an aspect of Psychological Flexibility as found 
in Luoma et al. (2007) but only used the measure to assess change in an 
intervention were excluded.  
3. Population – to be included a paper needed to have used participants who have 
some form of chronic health condition (e.g. chronic pain, epilepsy, cancer). If a 
paper included several populations (e.g. a student population and a chronic pain 
population), then this paper was included if it was possible to assess the health 




Following the identification of potential literature using the search strategy, these 
papers were interrogated using the above inclusion and exclusion criteria. Papers 
were screened initially by title, then by abstract and finally following a complete 
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read through of the remaining papers. One author (LJSG) completed this process, 
with any queries being discussed with a second author (NF). 
 
Risk of bias assessment 
A quality assessment tool specific to the aims of this review was developed 
(supplementary file S2.2). One author (LJSG) reviewed all papers using this tool. 
Another author (KK) reviewed a third of the papers in order to assess the reliability 
of the tool. A kappa agreement score was developed to assess the similarity of the 
two rater’s scores. Following this, any disagreements were discussed and resolved 
for the dual rated papers to arrive at the final ratings for each paper. Any 
disagreements that could not be resolved between the two raters were discussed 
with another author (DG). 
 
Assessing the quality of the measures 
In order to assess whether the measures themselves are of sufficient quality, the 
following criteria were used (adapted from van Saane and colleagues (2003). 
Internal consistency should be 0.80 or higher and test-retest reliability should be 
0.70 or higher. Regarding construct validity; for convergent validity (assessing the 
current measure against another measure that purports to measure the same 
construct) the correlation between these should be 0.50 or higher and for 
discriminant validity (the current measure is associated with another measure that 
assesses a similar but distinct concept), the correlation between them should be 
0.50 or lower. For content validity, whether or not the questions used in the 
measure relate to the construct under measurement needs to have been 
established. This could be completed in several ways, for example, having the 
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measure assessed by an expert in the field as clearly assessing the construct, or 
using a translation process that involves ascertaining that translated questions 
remain related to the original concept. Finally, criterion validity was assessed as 
sufficient if the measure was assessed against other constructs that are 
hypothesised to be related to the construct under investigation, and correlations 
with these constructs were at the magnitude and direction previous literature would 
suggest. The overall quality criteria are included in box 2.1. 
 
Internal Consistency >0.80 





Measure’s questions clearly relate to 
overall construct 
Criterion 
Measure correlates with related concepts 
as hypothesised by previous literature 
Box 2.1 – Quality criteria for the measures under investigation, adapted from van 
Saane et al. (2003). 
 
Data synthesis strategy 
Due to the likely heterogeneity of the studies in terms of the diverse populations 
likely to be identified and the many different measures, a meta-analytical synthesis 
was not proposed. Therefore, a narrative synthesis of the data from each paper will 
be completed. The main data to be extracted will be the tools in use in a clinical 
health population, the reliability and validity of these tools, the aspects of 
Psychological Flexibility that are assessed by these tools and elements about the 
usability of these tools. ‘Usability’ covered elements such as whether these tools 
were free to use, their length, whether they were easy to score or interpret and 






Figure 2.4 shows the study selection process for this review. In brief, 471 records 
were identified and 30 were remaining at the end of the study selection process for 
inclusion in the review. Figure 2.4 also denotes the reasons for papers being 
excluded.  
 





Quality ratings for each of the studies is included in Table 2.2. Inter-rater reliability 
of the one third of the sample that was originally co-rated revealed a Kappa of 0.49 
which is under 0.70, the level considered satisfactory (Pallant, 2010). It became 
clear that the majority of disagreement was between poor and adequate or 
adequate and well, with very few instances where there was disagreement between 
poor and well. This suggests that it was the finer grading included in the quality 
criteria that made inter-rater reliability less accurate. The finer grading issue was 
discussed between the raters to gain greater clarity. Following this, it was agreed 
that the co-rater would rate the remaining two thirds of papers. This was with the 
aim of ensuring that the final quality ratings for each paper were the combination of 
both raters’ decisions regarding the quality of each paper in an attempt to reduce 
bias. The inter-rater agreement improved following this process and the final Kappa 
level for all papers combined was 0.68. Although this was still below the commonly 
described level of 0.70, it did represent an improvement from the original inter-rater 
agreement. Please note this Kappa score does not include the score for the ‘overall 
validity’ or ‘overall reliability’ ratings. This is because these ratings are based purely 
on previous ratings and would have therefore skewed the Kappa score.  
 
Overall the rating for the studies revealed they were of fairly poor quality. Internal 
consistency was often reported accurately and rated as ‘well covered’, whereas test 
re-test reliability was often not assessed. This led to several papers being rated 
poorly for overall reliability, as they tended to claim that reliability of the scale had 
been established in the conclusions, despite only part of reliability being assessed. 
Regarding validity, there was a mix across the papers; several were rated as poorly 
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assessing validity, whereas others did manage to assess validity in an adequate or 
well covered way.  Sample size was rarely assessed a priori and often the adequacy 
of the sample size for the analysis being used was not discussed at all. This has 
resulted in sample size being rated as poorly addressed across the majority of the 
studies. Sample representativeness was also often rated as poor. Despite samples 
often being well described, the samples used were limited to a more specific 
population (for example, individuals with chronic pain attending a specialist pain 
service in one geographical area) and therefore this limits the generalisability of the 
overall results. The usability of the scale under investigation (for example is it short, 
easy to use/administer or easy to score) was rarely discussed in the included studies 
and therefore, was again, rated as poorly addressed in most studies. The 
discussions of most papers were rated highly as indicated by positive rating of the 
conclusions being in line with the data, the implications of the study on the wider 




Characteristics for each study can be seen in Table 2.1. Despite including studies 
that had any health population, the majority of studies (80.0%) included a chronic 
pain population. Some studies used a specific chronic pain population, for example 
fibromyalgia (e.g. Yu et al., 2017) or whiplash associated disorder (Wicksell et al., 
2009), but most included a heterogeneous chronic pain population defined as 
individual’s experiencing pain for three months or more. Other samples found in the 
review were; people with tinnitus (Weise et al., 2013), cardiovascular disease 
(Spatola et al., 2014), irritable bowel syndrome (IBS) (Ferreira et al., 2013), Multiple 
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Sclerosis (MS) (Gillanders, et al., 2014) and epilepsy (Lundgren et al., 2012). The 
studies included have a high proportion of women participants. Over all the studies 
there was an average of 70.15% female participants. Most studies assessed 
elements of both reliability and validity, two assessed only reliability (Bailey, 2016; 
Weise et al., 2013), and three assessed only validity (Lundgren et al., 2012; Pielech 
et al., 2016; Wicksell et al., 2008). Studies assessed questionnaires in a variety of 
languages and those that were both population specific and generic measures. 
Measures were identified that attempted to measure Psychological 
Flexibility/Inflexibility as a whole (e.g. Han et al., 2017) and those that attempted to 
measure individual parts of the hexaflex such as values (e.g. Åkerblom et al., 2017). 
 
Reliability and Validity of Measures 
Tables 2.3 and 2.4 combine the results across the studies found in this review on 
the different measures for those measuring Psychological Flexibility (Table 2.3) and 
those that are measuring separate elements of the hexaflex (Table 2.4). The quality 
criteria used to assess the measures can be found in box 2.1. 
 
Measures of Psychological Flexibility/Inflexibility 
Psychological Inflexibility in Pain Scale (PIPS): The PIPS was the most well 
researched measure of Psychological Flexibility across this review. Reliability and 
validity of this measure has been established across all the studies using the PIPS. 
However, the studies using the PIPS are, in reality, using measures that are either 
of different lengths, for example, 16 items (Wicksell et al., 2008) instead of 12 items 
(Wicksell et al., 2010) or using different language versions (e.g. Trompetter et al., 
2014). Each individual iteration of the PIPS has not had their psychometric 
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properties fully established, with the exception of the Spanish version of the PIPS 
(Rodero et al., 2013). 
Brief Pain Response Inventory (BPRI): English and Korean versions of this were 
assessed in this review. The Korean version of this scale has established 
psychometric properties with the exception of construct and criterion validity which 
has not been established (Han et al., 2017). For the English version of this scale, 
only construct validity and internal consistency has been established (McCracken et 
al., 2010). 
Brief Pain Coping Inventory – 2 (BPCI-2): This is the longest measure of 
Psychological Flexibility/Inflexibility included in the review (19 items). The validity of 
this measure has been assessed (McCracken & Vowles, 2007), however, the 
reliability (both internal consistency and test re-test reliability) have not been 
established. Of the English Psychological Flexibility/Inflexibility measures identified 
through this review, the BPCI-2 is the most psychometrically robust. 
Cardiovascular Disease Acceptance and Action Questionnaire (CVD-AAQ): This 
Italian questionnaire is specific to a Cardiovascular Disease (CVD) patient 
population. Both reliability and validity have been established for this measure with 
the exception of internal consistency which did not meet the required level of 0.80. 
(Spatola et al., 2014). It is also one of the shortest measures found, containing 
seven items.  
 
Overall, the complete psychometric properties of measures of Psychological 
Inflexibility/Flexibility has not been established or investigated for any measure 
included in this review with the exception of the Spanish version of the PIPS 
(Rodero et al., 2013). However, this measure is limited in the fact that it is only 
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suitable for native Spanish speakers and it was conducted on individuals with 
fibromyalgia. Information regarding measures of Psychological 
Flexibility/Inflexibility’s usability is also missing from the included studies. The length 
of the measures of Psychological Flexibility/Inflexibility is reasonably short, ranging 
from 7-19 items. All measures identified in this study are population specific (all 
chronic pain except the CVD-AAQ which is for CVD populations). 
 
Measures of elements of the hexaflex 
Acceptance: All measures of acceptance found in this review were designed to be 
population specific, including the Chronic Pain Acceptance Questionnaire (CPAQ) 
and its shorter form (CPAQ-8), the Acceptance of Irritable Bowel Syndrome 
(IBSAAQ), the Multiple Sclerosis Acceptance Questionnaire (MSAQ) and the Tinnitus 
Acceptance Questionnaire (TAQ). The CPAQ has both English and Swedish versions. 
The English version has only had its internal consistency and criterion validity 
assessed (e.g. Fish et al., 2010), whilst the Swedish version had these and Content 
Validity assessed (Wicksell et al., 2009). The shorter version of eight items (CPAQ-
8) was only found in English in this review and demonstrated reasonable 
psychometric properties (Fish et al., 2010; Fish et al., 2013) with only content and 
construct validity not being established. The IBSAAQ was assessed in one study 
(Ferreira et al., 2013) and this demonstrated psychometric properties of the 
measure across all elements of reliability and validity assessed in this review. The 
MSAQ also demonstrated reasonable psychometric properties with all but test-retest 
reliability being established (Pakenham et al., 2011). The German TAQ has not had 
its psychometric properties established, with only data on internal consistency being 
found in this review (Weise et al., 2013). 
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Cognitive Fusion: The cognitive fusion questionnaire (CFQ) was the only measure 
identified in the included papers that assessed cognitive fusion specifically. This 
measure has seven items (although an older version assessed in one paper 
contained 13 items; McCracken et al., 2014). Despite the paper included in this 
review (Gillanders et al., 2014) discussing the validation of the CFQ across other 
samples more fully, within the context of physical health conditions the English 
version of the seven item CFQ has had its reliability and validity established in 
participants with MS with the exception of test-retest reliability and construct 
validity. Scale usability was also discussed for the English version of the CFQ with its 
suitability for clinical practice due to its length, its simple language increasing 
acceptability and the generic nature of the scale making it suitable across clinical 
and research settings being highlighted. A French version of the seven item CFQ 
was also found in this review and its psychometric properties were established 
within a French speaking Canadian sample, with the exception of test-retest 
reliability (Dionne et al., 2016).  
Committed Action: This review identified several iterations of the Committed Action 
Questionnaire (CAQ) including the original 18 item CAQ, the shorter eight item 
version (CAQ-8) and the Chinese translation of the short version (ChCAQ-8) all of 
which are not population specific. Swedish and English versions of the CAQ and the 
CAQ-8 and a French version of the CAQ-8 were found. The Swedish versions 
demonstrated similar psychometric properties to each other with all but test-retest 
reliability being established (Åkerblom et al., 2016). The English CAQ version 
demonstrated good psychometric properties with again, all but test-retest reliability 
and criterion validity being established (Bailey, 2016). Regarding the shorter English 
language version of the CAQ-8, neither test-retest reliability nor content validity 
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were established in this review (McCracken, 2013). The French CAQ-8 demonstrated 
good psychometric properties with all but test-retest being established in this review 
(Gagnon et al., 2017). Finally, a Chinese version of the CAQ (the ChCAQ-8) failed to 
demonstrate internal consistency, construct validity or test-retest reliability in this 
review (Wong et al., 2016). 
Experiential Avoidance: Only one measure for experiential avoidance was identified 
in this review, the Acceptance and Action Questionnaire-II, Pain Version (AAQ-II-P) 
which is population specific to individuals with chronic pain. Only construct validity 
and internal consistency has been demonstrated in this seven-item questionnaire in 
this review (Reneman et al., 2014). 
Self as Context: Again, only one measure for self as context was identified; the Self 
Experiences Questionnaire (SEQ). This eleven-item questionnaire is not population 
specific, however was only assessed with a chronic pain and fibromyalgia population 
in this review. Across these two studies, all but test-retest reliability was established 
(Yu et al., 2016; Yu et al., 2017). 
Values: Both population specific and generic measures of values were identified. Of 
the generic measures, the Bull’s Eye Value Survey has not adequately demonstrated 
reliability or validity in this review (Lundgren et al., 2012). The second generic 
measure, the Values Tracker (VT), demonstrated only criterion validity, but a paper 
did discuss how its length (two items) made it easy to use and administer (Pielech 
et al., 2016). The Chronic Pain Values Inventory (CPVI), is a measure of values 
specifically designed for a chronic pain population. The CPVI is in Swedish and 
validity was established in this review (Åkerblom et al., 2017), but reliability was not 




Risk of bias across studies  
Some studies were conducted by the same author group and appeared to be 
recruiting from the same population (e.g. McCracken et al., 2010 and McCracken et 
al., 2014). Although it is not clear that the same participants are being used, the 
population from which the participants are being recruited from do appear to be the 
same. This would limit the generalisability of the overall synthesis of the results as, 
despite there being several papers assessing the reliability and validity of a 
measure, the population (e.g. a specialised chronic pain service in one geographical 
area) the samples are being recruited from is the same and therefore it is less clear 
how valid or reliable the measure may be in a different population; for example, one 
that is taken from a different area of the country or a different pain service with 
















Measure All or part of 
PF? 

























n.r. No yes Swedish 
Åkerblom  
(2017) 
Chronic Pain 85.3 Both n.r. CPVI Part 
(Values) 

















n.r. No no English 
Barke  
(2015) 





Chronic Pain 79.6 Both 0.94 CFQ Part 
(Cognitive 
Fusion) 
7  n.r. No yes French 
Ferreira  
(2013) 
IBS 88.4 Both 0.89 IBSAAQ Part 
(Acceptance) 







































Chronic Pain 78.4 Both 0.86 CAQ-8 Part 
(Committed 
Action) 
8  n.r. No no French 
Gillanders  
(2014) 
MS 72.0 Both 0.93 CFQ Part 
(Cognitive 
Fusion) 
7  n.r. No yes English 
Han  
(2017) 

























Chronic Pain 62.5 Both 0.91 CAQ Part 
(Committed 
Action) 
18  n.r. No no English 
McCracken  
(2014) 
Chronic Pain 67.8 Both 0.87 CFQ Part 
(Cognitive 
Fusion) 
13  n.r. No no English 
McCracken  
(2015) 
Chronic Pain 62.0 Both 0.87 CAQ-8 Part 
(Committed 
Action) 
8  n.r. No no English 
Pakenham  
(2011) 
MS 85.0 Both 0.83 MSAQ Part 
(Acceptance) 





Chronic Pain 64.8 Validity n/a VT Part 
(Values) 
2  n.r. No yes English 
Reneman  
(2014) 
Chronic Pain 73.0 Both 0.87 AAQ-II-P Part 
(Experiential 
Avoidance) 





Table 2.1 – Relevant characteristics of each of the included studies.  
* It is not clear whether this α level is for the whole scale of 15 items or for the cut down scale of 11 items 
Rodero  
(2013) 
















Tinnitus 39.4 Reliability 0.86 TAQ Part 
(Acceptance) 

























Chronic Pain 70.0 Both 0.75 ChCAQ-8 Part  
(Committed 
Action) 




Chronic Pain 65.2 Both 0.90 SEQ Part  
(Self as 
Context) 
15  n.r. No no English 
Yu  
(2017) 













n.r. No no English 
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** Authors claim to measure all of Psychological Flexibility, but in reality, only measures two parts of the hexaflex (Avoidance and 
Cognitive Fusion). 
Abbreviations: Pop (Population; PF (Psychological Flexibility); n.r. (not reported); α (Chronbach’s alpha level); n/a (not applicable); IBS 
(Irritable Bowel Syndrome); CVD (Cardiovascular Disease); WAD (Whiplash Associate Disorder); CAQ (Committed Action Questionnaire); 
CAQ-8 (Committed Action Questionnaire – Short Form); CPVI (Chronic Pain Values Inventory); PIPS (Psychological Inflexibility in Pain 
Scale); CFQ (Cognitive Fusion Questionnaire); IBSAAQ (Acceptance of Irritable Bowel Syndrome Questionnaire); CPAQ (Chronic Pain 
Acceptance Questionnaire); CPAQ-8 (Chronic Pain Acceptance Questionnaire – Short Form); K-BPRI (Korean Version of Brief Pain 
Response Inventory); BPCI-2 (Brief Pain Coping Inventory – 2); BPRI (Brief Pain Response Inventory); MSAQ (Multiple Sclerosis 
Acceptance Questionnaire); VT (Values Tracker); AAQ-II-P (Acceptance and Action Questionnaire II - Pain Version); CVD-AAQ 
(Cardiovascular Disease Acceptance and Action Questionnaire); TAQ (Tinnitus Acceptance Questionnaire); ChCAQ-8 (Chinese Version of 





































Åkerblom et al. (2017) + n/a ++ ++ ++ + - - + + + 
Åkerblom et al. (2016) ++ n/a - ++ ++ + - + ++ ++ ++ 
Bailey (2016) ++ n/a - - - - - - ++ + ++ 
Barke et al. (2015) ++ n/a ++ ++ ++ + - - + + ++ 
Dionne et al. (2016) n/a n/a ++ + ++ ++ - - ++ ++ ++ 
Ferreira et al. (2013) ++ ++ ++ + + - - + - + ++ 
Fish et al. (2010) ++ n/a - - ++ - - ++ - + ++ 
Fish et al. (2013) ++ ++ ++ - ++ - - - ++ ++ ++ 
Gagnon et al. (2017) ++ n/a ++ ++ ++ - - + + ++ ++ 
Gillanders et al. (2014) 
(Sample 5) 
++ n/a ++ + ++ ++ - + ++ ++ ++ 
Han et al. (2017) ++ ++ - + - - ++ - + + ++ 
Lundgren et al. (2012) 
(Study 1) 
n/a n/a - - - - - - - - + 
McCracken & Vowles 
(2007) 
+ n/a + + ++ - - - ++ + ++ 
McCracken (2013) ++ n/a + ++ - + ++ - ++ ++ ++ 
McCracken et al. (2010) ++ n/a - + - ++ - - - + ++ 
McCracken et al. (2014) ++ n/a - - + - - - + + ++ 
McCracken et al. (2015) ++ n/a ++ - ++ + - - ++ + ++ 
Pakenham & Fleming 
(2011) 
n/a n/a ++ + + - - - ++ + + 
Pielech et al. (2016) n/a n/a ++ - - ++ - - + + ++ 
Reneman et al. (2014) ++ n/a ++ - - - - - ++ + + 
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Rodero et al. (2013) ++ ++ + ++ ++ - + - + + ++ 
Spatola et al. (2014) ++ ++ ++ + ++ - - - ++ ++ + 
Trompetter et al. (2014) ++ n/a - + - - - - ++ ++ ++ 
Weise et al. (2013) n/a n/a n/a n/a n/a + - - ++ ++ ++ 
Wicksell et al. (2009) ++ n/a - - + - ++ ++ ++ ++ + 
Wicksell et al. (2008) n/a n/a - - - - - - ++ - ++ 
Wicksell et al. (2010) n/a n/a ++ - ++ - - + ++ + ++ 
Wong et al. (2016) ++ n/a - ++ ++ + - - ++ ++ ++ 
Yu et al. (2016) ++ n/a ++ + + - - ++ ++ ++ ++ 
Yu et al. (2017) + n/a - - - - - - + + ++ 
 
Table 2.2 – Quality assessment of included studies. ++ (well covered); + (adequately covered); - (poorly covered); n/a (not applicable). 
Quality Criteria in full are: 1 (reliability – Internal Consistency), 2 (Reliability – Test-retest), 3 (Reliability – Overall*), 4 (Validity – 
Construct), 5 (Validity – Content), 6 (Validity – Criterion), 7 (Validity – overall*), 8 (Scale Usability), 9 (Sample Size), 10 (Sample 
Representativeness), 11 (Study Implications Defined), 12 (Conclusions follow on from data), 13 (Limitations of study outlined). 
* Please note it was decided not to include ‘Reliability – Overall’ and ‘Validity – Overall’ within the reporting of quality criteria as these 





























   15 n.r. 
Chronic Pain English  
(0.84) 
    15 n.r. 
BPCI-2 Yes Chronic Pain English      19 n.r. 
CVD-
AAQ 




   7 n.r. 
PIPS Yes 
Chronic Pain Swedish  
(0.89) 
    16 n.r. 
Chronic Pain Swedish      12 n.r. 




   12 n.r. 
Chronic Pain German  
(0.78) 
    11 n.r. 
Chronic Pain Dutch  
(0.88) 
    12 n.r. 
Table 2.3 – Measures of Psychological Flexibility/Inflexibility 
40 
 
Abbreviations: BPRI (Brief Pain Response Inventory); BPCI-2 (Brief Pain Coping Inventory – 2); CVD-AAQ (Cardiovascular Disease 
































    20 n.r. 
WAD Swedish  
(0.91) 
    19 n.r. 






   8 Yes 










    16 n.r. 
TAQ Yes Tinnitus German  
(0.86) 
    12 n.r. 
Cognitive Fusion 
CFQ No 
Chronic Pain English  
(0.87) 
    13 n.r. 
MS English  
(0.93) 























Chronic Pain French  
(0.94) 
    7 Yes 
Committed Action 





    8 Yes 
CAQ No 
Chronic Pain Swedish  
(0.89) 
    18 Yes 




    18 n.r. 
Chronic Pain English  
(0.91) 
    17 n.r. 
CAQ-8 No 
Chronic Pain Swedish  
(0.84) 
    8 Yes 
Chronic Pain English  
(0.87) 
    8 n.r. 
Chronic Pain French  
(0.86) 
    8 n.r. 
Experiential Avoidance 
AAQ-II-P Yes Chronic Pain Dutch  
(0.87) 























Self as Context 
SEQ No 
Fibromyalgia English  
(0.94) 
    11 n.r. 
Chronic Pain English  
(0.90) 









     3 parts n.r. 
CPVI Yes Chronic Pain Swedish      12 Yes 
VT No Chronic Pain English      2 Yes 
Table 2.4 – Measures of individual elements of the hexaflex 
Abbreviations: IBS (Irritable Bowel Syndrome); WAD (Whiplash Associate Disorder); CAQ (Committed Action Questionnaire); CAQ-8 
(Committed Action Questionnaire – Short Form); CPVI (Chronic Pain Values Inventory); CFQ (Cognitive Fusion Questionnaire); IBSAAQ 
(Acceptance of Irritable Bowel Syndrome Questionnaire); CPAQ (Chronic Pain Acceptance Questionnaire); CPAQ-8 (Chronic Pain 
Acceptance Questionnaire – Short Form); MSAQ (Multiple Sclerosis Acceptance Questionnaire); VT (Values Tracker); AAQ-II-P 
(Acceptance and Action Questionnaire II - Pain Version); TAQ (Tinnitus Acceptance Questionnaire); ChCAQ-8 (Chinese Version of the 




This review investigated what assessment measures of Psychological Flexibility and 
its component parts have been developed and psychometrically assessed in a 
chronic health population. Thirty papers were identified that assessed the 
psychometric properties of measures designed to assess both Psychological 
Flexibility as a whole and the separate elements of the hexaflex. The reported 
reliability, validity and usability of these measures was discussed.  
 
Four measures were identified that attempted to measure Psychological Flexibility as 
a whole; the BPRI, the BPCI-2, the CVD-AAQ and the PIPS. These measures were 
developed in a variety of languages and not all of them have been validated in a 
health population in English. This review found that the PIPS was the most often 
researched measure of Psychological Flexibility in a health population, and the 
psychometric properties of the Spanish version of the PIPS was the most well 
demonstrated (Rodero et al., 2013). In the original study (Wicksell et al., 2008), the 
PIPS was developed with the aim to measure multiple elements of the hexaflex. 
However, following factor analysis the scale was cut down in such a way that the 
remaining items only pertained to two parts of the hexaflex, avoidance and 
cognitive fusion. Despite this, the authors continue to describe this measure as a 
measure of Psychological Flexibility as a whole, and it is questionable whether this 
description is warranted due to the format of the final scale only assessing two 
elements of the hexaflex. Studies that follow on from this original study by other 
research teams do not often explicitly recognise this limitation of the PIPS, instead 
conceptualising it as only a measure of Psychological Flexibility (e.g. Rodero et al., 
2013). Due to this confusion surrounding what the PIPS actually measures, the 
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psychometric properties are difficult to assess as construct validity was often 
assessed against measures of Psychological Flexibility. This might suggest that the 
PIPS does measure Psychological Flexibility as a whole, however it might also mean 
that the PIPS is correlating with other measures of Psychological Flexibility as it is 
measuring some aspects of Psychological Flexibility, and therefore any correlation is 
indicating the closeness of these concepts. Future research could compare 
correlations of scores on the subscales of the PIPS with scores on measures 
designed to specifically measure avoidance and cognitive fusion and establish 
whether it is better correlated with these measures compared to measures of 
Psychological Flexibility. Of the English language measures of Psychological 
Flexibility identified in this review, the BPCI-2 has more psychometric properties 
established than the others. The BPCI-2 is population specific (chronic pain) so 
cannot be used in other populations.  
 
Overall this review identified that measures of Psychological Flexibility that are 
validated in health populations are limited, with those that were identified being 
specific to a set population, most of which were chronic pain. There are several 
newer measures of Psychological Flexibility (e.g. the compACT, Francis et al., 2016; 
the MPFI, Rolffs et al., 2016) which aim to measure all elements of the hexaflex that 
make up Psychological Flexibility. These have had their psychometric properties 
assessed and established in other populations (Francis et al., 2016; Rolffs et al., 
2016), but not explicitly in chronic ill health populations. Much research looking at 
the effectiveness of interventions based on ACT in health conditions assess changes 
in Psychological Flexibility using measures that have not been explicitly validated in 




This review also identified scales that aimed to measure specific elements of the 
hexaflex. Measures for acceptance, cognitive fusion, committed action, experiential 
avoidance, self as context and values were identified. Some of these concepts are 
opposite points of the hexaflex, such as experiential avoidance and acceptance, 
whilst others such as ‘values’ could be measuring either ‘defining valued directions’ 
or a ‘lack of values clarity/contact’. Many measures suggest that both elements of 
Psychological Inflexibility and Psychological Flexibility can be assessed with one 
scale with extremes of scores denoting greater Psychological Flexibility/Inflexibility 
depending on how the scale is measured. Other authors, however, have found that 
Psychological Flexibility and Inflexibility are better understood as two distinct 
concepts and perhaps it is not possible to assume that individuals who score low on 
a measure of Psychological Flexibility are psychologically inflexible (Rolffs et al., 
2016). It is possible that this difference in findings across the literature is related to 
differences in the way these measures are assessed. Alternatively, it could suggest 
that the underlying processes driving aspects of Psychological Flexibility/Inflexibility 
(i.e. avoidance and acceptance) are different. Of the measures identified, only 
IBSAAQ has had all its psychometric properties assessed and rated as adequately 
covered in this review. This measure is specifically designed to measure acceptance 
in IBS sufferers and therefore, cannot be used in a diverse number of settings. Most 
measures did not discuss how usable they are, however the chCAQ-8, CPAQ, CPVI, 
CFQ, CAQ, CAQ-8, and the VT have all had their usability discussed, often in terms 
of the shortness of the scale decreasing the burden on participants (Pielech et al., 
2016) or accessibility of wording designed to make it more acceptable for use in a 




This review identified that many measures of Psychological Flexibility or its elements 
have been developed, but that their psychometric properties fail to be fully 
established. Clinical research is often using these measures in chronic health 
condition populations despite these measures not being fully validated (e.g. Wicksell 
et al., 2010). As a wide range of measures were identified, with many having 
elements of psychometric properties being established, future research could focus 
on establishing the reliability and validity of these existing measures more fully, 
rather than the development of additional measures that are only partially validated. 
This would help to identify those measures that are more robust and those that do 
not stand up to increased scrutiny and therefore, identify any gaps where more 
improved measures are required before the development of novel measures. Test-
retest reliability was the element of reliability most often not assessed and future 
research could aim to assess test-retest reliability in the measures identified in this 
review to attempt to fill this gap in the evidence base.  
 
This review also found that samples tended to have a higher percentage of women 
in them. Some populations investigated are more likely to be diagnosed in women, 
for example women are ten times more likely to be diagnosed with Fibromyalgia 
(Chakrabarty & Zoorob, 2007). However, other populations such as IBS have 
identified less difference between genders with a female to male gender ratio of 
1.67:1 found in one review (Lovell & Ford, 2012), suggesting that the samples used 
were biased towards women in their recruitment. Some research has demonstrated 
that there is a gender difference in some aspects of Psychological Flexibility with 
men scoring significantly higher than women (Reneman et al., 2014). Future 
48 
 
research could attempt to assess Psychological Flexibility in populations that have a 
higher male proportion such as some cancers in order to assess whether these 
measures are valid and reliable in male populations as well.  
 
The samples were also more likely to be focussed on chronic pain populations, even 
when assessing measures that are designed to be non-population specific (e.g. 
Åkerblom et al., 2016). This limits the generalisability of the literature identified as a 
whole, as it is difficult to ascertain whether these measures are appropriate to use 
in a range of chronic health conditions or purely appropriate for a chronic pain 
population. Many of the measures assessed in other populations, such as the MSAQ 
or IBSAAQ are population specific (MS and IBS respectively) and therefore, cannot 
be applied to other health populations. Future research could assess the generic 
measures of both Psychological Flexibility and elements of the hexaflex identified in 
this review in more diverse ill health populations to establish the applicability of 
these in different populations and to attempt to establish whether the pattern of 
responding to these generic measures differ depending on the health population 
under investigation.  
 
This review also aimed to assess the usability of the measures identified in order to 
make recommendations on their usefulness for clinical settings. Very few papers 
discussed the usability of the scale, either for the clinician, or even more rarely for 
the participant. No papers explicitly identified whether their scale was free to use, 
however, some authors did state that the measure was available from the author 
(McCracken & Vowles, 2007), or available on a website (Gillanders et al., 2014), 
however it was not clear whether this meant the scale was free to use. This is of 
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particular relevance to publicly funded healthcare contexts, such as the UK National 
Health Service (NHS) where resources are limited and scales that are accessible free 
of charge are important. Future research looking at developing new scales, or 
further evaluating the psychometric properties of existing ones should include in 
their description of the scale information that allows the reader to readily establish 
how easy the scale is to administer, score and interpret, the burden it creates for 
the participant and whether there is a cost to using it. This information, in addition 
to the psychometric evaluation of measures would make it much easier for busy 
researchers and clinicians to quickly identify the most suitable measure for their 
context. 
 
The concept of Psychological Flexibility is one that is still being developed and 
added to, with some researchers more recently suggesting a model of three 
overarching themes that combines elements of the hexaflex in to subgroups (Hayes 
et al., 2010). This ever-changing nature of the concept of Psychological Flexibility, 
whilst in some ways can be thought of as a strength of the model, presents 
significant challenges when trying to apply traditional psychometric rigour to these 
concepts. A second difficulty is that the processes underlying Psychological 
Flexibility (elements of the hexaflex) are all interlinked and together form the 
construct of Psychological Flexibility. There has been controversy in the literature 
surrounding whether measures of Psychological Flexibility need to explicitly measure 
all elements of the hexaflex, or to measure it in a way that adequately captures the 
overarching idea of Psychological Flexibility and does not need to necessarily 
explicitly measure each component part (Rolffs et al., 2016). Within psychometric 
traditions, construct validity, by its very nature, is assessing whether a measure 
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truly measures what it is aiming to measure, and it is assumed that the concept that 
we are trying to measure is a concrete construct and psychometric research 
attempts to find the optimal way of measuring it. This leads to a query of whether 
psychometric measures are the best way of measuring ACT processes as it does not 
appear to fit with the core principles and values of the ACT model.  
 
In describing this tension between psychometric science and the a-ontological 
position of contextual behavioural science, some authors (Jeffcoat et al., 2015) have 
proposed a metaphor of them being like two different peoples, speaking different 
languages. In this metaphor, it is not that the concepts being described by the two 
peoples are incompatible, rather, that each need to be able to speak and 
understand each other’s languages. This metaphor could be extended, as in reality, 
it is not the two different ‘languages’ alone that cause difficulty in interpreting the 
reliability and validity of measures of Psychological Flexibility, it is that the 
philosophical science underpinning the theory of Psychological Flexibility does not 
view the concepts as essential or absolute. Instead, theories are judged in relation 
to how workable or useful they are in producing effective behavioural actions, 
rather than how well they correspond with an external ontological reality. Language 
has many diverse and nuanced elements as it develops in a context. This can be 
seen in countries having multiple names for similar things, often in response to the 
usefulness of being able to delineate between finer differences in concepts. A good 
example of this could be to think about rain. Rain in its most basic form is water 
falling from the sky, and to teach another individual this word, one could point to 
the water falling from the sky and call it rain. However, within a language there may 
be many words or phrases for rain such as; ‘bucketing it down’, ‘drizzle’, ‘mizzle’ and 
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‘pouring’. Therefore, by naming it solely as rain, the complexity of the language is 
missed. In addition, those only taught the word rain are unlikely to be able to 
understand conversations about the weather when a plethora of words to describe 
the water falling from the sky are commonly used. In a similar way, by using a 
psychometric method to conceptualise Psychological Flexibility this results in a 
reduction of a complex, nuanced and ever-changing concept to specific concrete 
constructs, which could be argued to no longer represent the original concept. In 
addition, when concrete measures are used, but discussions within the contextual 
science community continue to include the many ways in which Psychological 
Flexibility is conceptualised, individuals from other areas of science may be excluded 
from the contextual science community as the complexity could be overwhelming 
and confusing if it is presented elsewhere as concrete. Therefore, whether 
psychometric scales are the best way to measure ACT concepts needs to be 
investigated with perhaps the use of other methodology such as individualised 
feedback within a qualitative research framework being developed as a more 
contextually-based alternative. 
 
This review has several limitations. As it aimed to assess only measures that had 
been explicitly validated in health populations, some measures found in this review 
may have been previously more fully validated in other populations. This is of 
particular relevance to content validity of a scale, which may have been assessed in 
other populations previously. This could mean that the current review has concluded 
that content validity has not been assessed, despite there being evidence for 
content validity elsewhere. However, this review would have identified if content 
validity was explicitly assessed in a health population which is an important finding 
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for clinicians and researchers attempting to decide what measure to use for 
evaluating Psychological Flexibility and its components within in a physical health 
population. Three papers were not available, two of these were due to them being 
theses that were not available online and could not be sourced directly from the 
authors and the final one was in a language that translation could not be sought 
for. It was difficult to find an explicit definition of what a chronic ill health condition 
was, resulting in the authors having to discuss queries of inclusion/exclusion and 
relying on a consensus view which may have resulted in a bias. For example, some 
papers were not included as it was felt that they were not a chronic ill health 
condition, such as papers using a traumatic brain injury population, as it was felt 
that as this population represents individuals who may (or may not) recover to a 
premorbid functioning level as well as individuals who may be left with chronic 
disability that it was not possible to establish the chronic nature of these conditions. 
This could limit the review as not all physical ill health conditions were included 
making this review limited to chronic ill health conditions only. This review also 
assessed specific elements of validity and reliability which were described by 
previous research as the elements that are core to the assessment of the 
psychometric properties (Saane et al., 2003). However, this means that other 
elements such as incremental validity or the factor analysis of scales was not 
assessed. Although this review did not automatically exclude any papers on the 
basis of language, very few papers were identified that were in other languages. 
This could be because search methods were limited to databases that primarily 






This review aimed to assess what measures of Psychological Flexibility and its 
component parts have been assessed as reliable and valid in chronic health 
populations. Only two measures of Psychological Flexibility were assessed as having 
all its psychometric properties as confirmed, the Spanish version of the PIPS (which 
is designed for people with chronic pain only) and the Italian CVD-AAQ (which is 
designed for use with people with CVD only). Of the measures of the individual 
elements of the hexaflex, only the IBSAAQ, which is designed to measure 
acceptance in patients with IBS, had confirmed psychometric properties across the 
board. This review identified that many measures have not been fully validated in a 
chronic ill health population. In relation to measures of Psychological Flexibility as a 
whole, this review suggested that measures that are generic and not population 
specific need to be developed and perhaps existing measures such as the compACT 
(Francis et al., 2016) and MPFI (Rolffs et al., 2016) that have been validated in 
other populations could be assessed with regards to their psychometric properties in 
an ill health population. With regards to measures of individual elements of the 
hexaflex the review suggested that the focus for future research might be better 
placed on further validation of existing measures with the aim of attempting to 
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*Keyword mapped to subject heading 
+ EXPLODE function used on keyword 






1 “Acceptance and Commitment Therapy”* OR “Psychological 
Flexibility” OR “Psychological Inflexibility” OR “Psychological 
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2 “Psychological Tests”*+ OR “Reproducibility of Results”*+ OR 
“Sensitivity and Specificity”*+ OR “Social Validity, Research”* OR 
“Validation Studies”* 
3 (Final) “Search 1” AND “Search 2” 
*Keyword mapped to subject heading 
+ EXPLODE function used on keyword 
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Reliability and Validity of psychometric measures of 





 Quality Criteria 
1 Reliability – Internal consistency 
2 Reliability – Test-retest  
3 Reliability - overall 
4 Validity – Construct  
5 Validity – Content 
6 Validity - Criterion 
7 Validity - overall 
8 Scale Usability 
9 Sample size 
10 Sample representativeness 
11 Study implications defined 
12 Conclusions follow from data 




1 – Reliability – Internal consistency – the consistency of results across items within 
a test.  
 
Well covered Reports assessment of internal consistency with an appropriate 
statistical correlational technique 
AND 
Interprets this accurately throughout the paper – e.g. using pre-
established criteria for what level the correlation is at, discusses 
the measure within the limits of the correlation strength (i.e. 
does not over extend in conclusions). 
Adequately 
addressed 
Reports assessment internal consistency with an appropriate 
statistical correlational technique 
BUT 
Does not interpret this correlational technique accurately using 
accepted criteria, or makes conclusions based on the outcome of 
statistical testing that are beyond the scope of their findings. 
Poorly 
addressed 
Study aims to assess reliability in its key aims, but does not 
mention or discuss internal consistency. 
OR 
Discusses internal consistency, but does not report assessing it 
using an appropriate statistical method or does not report the 
outcomes of any statistical methods proposed/used. 
Not applicable Study does not aim to assess reliability in its key aims 
Notes  
 
2 – Reliability – Test-retest -  The degree to which test scores are consistent from 
one testing to another. 
 
Well covered Reports assessment of test-retest reliability with an appropriate 
statistical correlational technique 
AND 
Interprets this accurately throughout the paper – e.g. using pre-
established criteria for what level the correlation is at, discusses 
the measure within the limits of the correlation strength (i.e. 
does not over extend in conclusions). 
Adequately 
addressed 
Reports assessment test-retest reliability with an appropriate 
statistical correlational technique 
BUT 
Does not interpret this correlational technique accurately using 
accepted criteria, or makes conclusions based on the outcome of 
statistical testing that are beyond the scope of their findings. 
Poorly 
addressed 
Study aims to assess reliability in its key aims, but does not 
mention or discuss inter-rater reliability. 
OR 
Discusses test-retest reliability, but does not report assessing it 
69 
 
using an appropriate statistical method or does not report the 
outcomes of any statistical methods proposed/used. 




3 –  Reliability – Overall.  
 
Well covered The authors report both forms of reliability assessed above and 
the paper was graded as “well covered” in both. 
Adequately 
addressed 




The authors only report one form of reliability regardless of how 
well they have reported it 
OR 
The authors report more than one form of reliability but both 
were judged to be “poorly addressed” or only one was 
“adequately addressed” 
Not applicable Study does not aim to assess reliability in its key aims 
Notes Note – if the paper meets two criteria, award the higher option. 
 
4 – Validity – Construct – The extent to which the test measures what it says is 
measures 
 
Well covered Reports assessment of construct validity. This could be through 
convergent validity (how correlated the tool is with another tool 
that purports to measure the same thing) or discriminant validity 
(how uncorrelated the tool is with another tool that purports to 
measure a different or similar construct). Appropriate statistical 
testing should be used. 
AND 
Interprets this accurately throughout the paper – e.g. using pre-
established criteria for what level the correlation is at, discusses 
the measure within the limits of the correlation strength (i.e. 
does not over extend in conclusions). 
Adequately 
addressed 
Reports assessment of construct validity. This could be through 
convergent validity (how correlated the tool is with another tool 
that purports to measure the same thing) or discriminant validity 
(how uncorrelated the tool is with another tool that purports to 
measure a different or similar construct). Appropriate statistical 
testing should be used. 
BUT 
Does not interpret this technique accurately using accepted 
criteria, or makes conclusions based on the outcome of 





Study aims to assess validity in its key aims, but does not 
mention or discuss construct validity. 
OR 
Discusses construct validity, but does not report assessing it 
using an appropriate statistical method or does not report the 
outcomes of any statistical methods proposed/used. 
Not applicable Study does not aim to assess validity in its key aims 
Notes  
 
5 – Validity – Content  - how well does the test cover all aspects of what it is trying 
to measure 
 
Well covered Reports that the measure was developed in a way that makes it 
possible for content validity to be assessed; including but not 
limited to; taking questions from other relevant measures, using 
experts (professional and by experience) to help develop 
questions, focus groups of appropriate individuals to generate 
questions. 
AND 
Reports assessing face validity of the measure in some way (e.g. 
would a non-expert observer know what the questionnaire is 
measuring from reading it). 
 
N.B. – in some cases it could be argued that face validity is not 
appropriate (e.g. if the test developers do not want the measure 
to be identifiable to someone filling in the measure), therefore if 
the authors specifically argue against the need for face validity, 
“well covered” can be given based on the first criterion alone. 
Adequately 
addressed 
Reports that the measure was developed in a way that makes it 
possible for content validity to be assessed; including but not 
limited to; taking questions from other relevant measures, using 
experts (professional and by experience) to help develop 
questions, focus groups of appropriate individuals to generate 
questions. 
OR 
Reports assessing face validity of the measure in some way (e.g. 
would a non-expert observer know what the questionnaire is 
measuring from reading it). 
Poorly 
addressed 
Study aims to assess validity in its key aims, but does not 
mention or discuss content or face validity. 
OR 
Discusses content or face validity, but does not report assessing 
it a way that allows the reader to make conclusions about the 
scales content or face validity. 
Not applicable Study does not aim to assess validity in its key aims 
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Notes Face validity is a related concept that is not technically part of 
content validity. However, for the purposes of keeping the 
number of criterion to a manageable level, face validity is being 
included under the umbrella of content validity. 
 
6 – Validity – Criterion – does the scale correlate with measures of constructs that 
are seen as relative to the construct under investigation? 
 
Well covered Reports assessment of criterion validity with either concurrent 
validity (does it correlate with a related construct at the time of 
testing) or predictive validity (do scores on the measure at time 
point one correlate with scores on another measure of a related 
construct at time two) using an appropriate statistical 
correlational technique 
AND 
Interprets this accurately throughout the paper – e.g. using pre-
established criteria for what level the correlation is at, discusses 
the measure within the limits of the correlation strength (i.e. 
does not over extend in conclusions). 
Adequately 
addressed 
Reports assessment of criterion validity with either concurrent 
validity (does it correlate with a related construct at the time of 
testing) or predictive validity (do scores on the measure at time 
point one correlate with scores on another measure of a related 
construct at time two) using an appropriate statistical 
correlational technique 
BUT 
Does not interpret this correlational technique accurately using 
accepted criteria, or makes conclusions based on the outcome of 
statistical testing that are beyond the scope of their findings. 
Poorly 
addressed 
Study aims to assess validity in its key aims, but does not 
mention or discuss criterion validity 
OR 
Discusses criterion validity (including concurrent or predictive), 
but does not report assessing it using an appropriate statistical 
method or does not report the outcomes of any statistical 
methods proposed/used. 
Not applicable Study does not aim to assess validity in its key aims 
Notes Note regarding predictive validity. Technically predictive validity 
needs to occur over two timepoints, for example construct X at 
timepoint 1 predicts construct Y at timepoint 2. However, in 
reality, predictive validity is often claimed from data collected at 
one timepoint. A paper that claims predictive validity from data 
at one timepoint can still be awarded “well covered” on criterion 
validity if they meet the criteria through concurrent validity. If 
the paper considers predictive validity alone from data collected 
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from one timepoint alone, the quality assessor needs to decide 
whether it was sufficiently well interpreted to be allowed a “well 
covered” rating or whether “adequately addressed” is better. To 
be well covered the authors should report clear reasoning for 
why (based on their theoretical model, or previous literature) 
they are able to claim that one construct is predicting another. 
Adequately addressed would be assigned if the authors do not 
justify their claiming predictive validity from data collected at 
one timepoint alone.  
 
7 –   Validity – Overall  
 
Well covered The authors report all three forms of validity assessed above and 
the paper was graded as “well covered” in at least two, with the 
third graded as adequately addressed if applicable. 
Adequately 
addressed 
The authors must have reported on construct validity at “well 
covered” or “adequately addressed” to get this grade in addition 
to: 
The other two forms at “adequately addressed” or “well 
covered” 
OR  
One other form only at “well covered” 
OR 




The authors only report one form of validity regardless of how 
well they have reported it 
OR 
The authors report more than one form of validity but all were 
judged to be “poorly addressed” or “adequately addressed” 
OR  
The paper was judged to have “poorly addressed” the construct 
validity.  
Not applicable Study does not aim to assess validity in its key aims 
Notes Note – if the paper meets two criteria, award the higher option. 
 
8 – Scale Usability 
 
Well covered The authors report detailed aspects of the scale other than 
reliability and validity that allow the reader to make conclusions 
about scale usability. For example, whether the scale is short, 
free to use, easy to understand, easy to score, easy to interpret, 
whether the authors have gained feedback from their 
participants regarding usability… 
Adequately The authors make some reference to scale usability, but do not 
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addressed go into much detail or provide many examples of how they are 
demonstrating scale usability. 
Poorly 
addressed 
The authors do not address aspects of scale usability 
OR  
The authors only say “the scale is easy to use” or something 
similar without discussing how the scale is easy to use. 
Not applicable The authors have stated that scale usability was well established 
in a previous paper that investigated the same scale and 
referenced this appropriately. 
Notes  
 
9 – Sample size 
 
Well covered Sample size required was reported as being assessed a priori and 
this sample size was reached 
Adequately 
addressed 
Sample size required was reported as being assessed a priori and 
this sample size was not reached, but conclusions of the paper 
were discussed in light of this. 
Poorly 
addressed 
Sample size was not discussed as being assessed a priori using a 
statistical method 
OR 
Sample size required was reported as being assessed a priori and 
this sample size was not reached and the authors do not discuss 
this or interpret the conclusions of the paper appropriately given 
this. 
Not applicable No sample was used 
Notes  
 
10 – Sample representativeness 
 
Well covered The study reports using sampling methods that would lead to a 
representative sample (e.g. methods that would not bias the 
population in any way, such as using only university students, or 
using a convenience sample) 
AND 
The study reports the variability of the sample on key 
demographic variables (e.g. age, ethnicity, education status), 




The study reports using sampling methods that would lead to a 
representative sample (e.g. methods that would not bias the 
population in any way, such as using only university students, or 
using a convenience sample) 
BUT 
Does not report the variability of the sample on key 
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demographic variables (e.g. age, ethnicity, education status). 
Poorly 
addressed 
The study does not report it’s sampling methods or the 
variability of the sample on key demographic variables 
OR 
The sampling methods are such that they create a bias in the 
sample e.g. using one population type only, or using a 
convenience sample. 
Not applicable No sample was used 
Notes  
 
11 – Study implications defined 
 
Well covered The implications of the results of the study for the wider 
research base and the population under study are clearly 
described and discussed.  
AND 
This follows clearly on from the literature introduced in the 
introduction 
AND 
Future possible research avenues are discussed (especially ways 
to move the science forward) 
Adequately 
addressed 
The implications of the results of the study for the wider 
research base and the population under study are adequately 
described and some discussion of this occurs. This is not well 
linked with the literature introduced in the introduction 
however. 
AND/OR 
Some future research avenues are suggested, but these are 
limited to how to improve the current study if it were redone 
and not suggestions of future research that would move the 
science forward.  
Poorly 
addressed 
The implications of the study for the wider research base or the 
population under study are not adequately described (briefly 
mentioned, without reference to literature introduced in the 
introduction) or not discussed. 
AND 
No future research avenues are suggested. 
Not applicable  
Notes There is no “not applicable” option. 
 
12 – Conclusions follow from data 
 
Well covered Conclusions are fully in line with the actual results of the paper. 
They do not over extend in any way. All data is discussed equally 
with no suppression or downplaying results/data that did not fall 
75 
 
in line with the proposed model. 
Adequately 
addressed 
Conclusions are, for the most part, in line with the actual results 
of the paper. The authors may suggest conclusions that seem a 
bit beyond the results of the paper, however this is done in a 
way that is clear what conclusions are from the results and which 
are more hypothetical ways the results could be interpreted, and 
the authors clearly acknowledge this.  
Some overenthusiastic interpretation of results is present, but 
this is not in a way that drastically changes the overall 
conclusions of the paper. 
There is some presence of suppression or downplaying 
results/data that did not fall in line with the proposed model. 
Poorly 
addressed 
Conclusions do not seem in line with the data, or are very over 
extended from the actual data gathered. The authors do not 
discuss, or largely downplay/supress results/data that did not fall 
in line with the proposed model. 
Not applicable  
Notes There is no “not applicable” option. 
 
13 – Limitations of study outlined 
 
Well covered The authors report the limitations of the study in clear detail 
including acknowledging weaknesses inherent in the methods 
they have used as well as limitations of the specific study. 
Examples include: acknowledging possible other conclusions for 
their results, discussing confounding/extraneous variables not 




The authors discuss limitations of the study in a broad sense, 
mentioning one or two forms of limitations inherent to their 
specific study, but not acknowledging other forms of limitations 
inherent to the methodology used. 
OR 
The authors have missed an important limitation or weakness of 
the study, but have discussed other forms of limitations well. 
Poorly 
addressed 
The authors do not report limitations of their study. 
Not applicable  
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Background: Individuals with cancer often experience fear that this cancer will get 
worse or return. Those with high levels of fear of recurrence experience greater 
psychological distress and poorer quality of life. Psychological Flexibility can be 
related to psychological distress and quality of life in cancer patients. How 
Psychological Flexibility might play a role in this relationship between fear of cancer 
recurrence and psychosocial outcomes of cancer has not been established 
previously.  
Methods: Fear of recurrence and Psychological Flexibility are less researched in 
men with prostate cancer. Therefore, this cross-sectional study initially used 
multiple regression to establish whether Psychological Flexibility and fear of 
recurrence might explain variance in the outcome variables of psychological distress 
and quality of life. To establish whether Psychological Flexibility might have a role to 
play in the relationship between fear of recurrence and outcome variables, 
conditional process analysis was used to assess whether Psychological Flexibility 
mediates or moderates the relationship between fear of recurrence and the 
outcome variables.  
Results: Psychological Flexibility was shown to significantly explain some of the 
variance in psychological distress and quality of life and appeared to be a stronger 
predictor of psychological distress than fear of recurrence. Fear of recurrence also 
significantly explained some of the variance in both outcome variables and was a 
stronger predictor of quality of life than Psychological Flexibility. The data revealed 
that there was evidence that Psychological Flexibility could be conceptualised both 
as a mediator or a moderator of the relationship between fear of recurrence and 
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psychological distress. For the relationship between fear of recurrence and quality of 
life, the data revealed there was only evidence for Psychological Flexibility acting as 
a moderator. 
Conclusions: These findings suggest that Psychological Flexibility might be a 
useful treatment target, through interventions such as Acceptance and Commitment 
Therapy, to improve psychosocial outcomes in men with prostate cancer. 
 
Keywords 
Psychological Flexibility; Prostate Cancer; Quality of Life; Psychological Distress; 




 Psychological Flexibility explains variance in psychosocial outcomes 
 Fear of cancer recurrence explains variance in psychosocial outcomes 
 Psychological Flexibility mediates fear of cancer recurrence and psychosocial 
outcomes  









Prostate cancer and Psychosocial Outcomes 
National Institute for Health and Care Excellence (NICE) guidelines (2014) indicate 
that for men, prostate cancer is the most common form of cancer, accounting for 
26% of all cancer diagnosed in men. Prostate Cancer impacts on psychosocial 
outcomes, including psychological distress, quality of life (QoL) and fear of cancer 
recurrence (FCR).  
 
Psychological distress 
Psychological Distress is defined differently throughout the cancer literature, 
however, the National Comprehensive Cancer Network (NCCN, 2013) definition is 
used most frequently:  
“Distress is a multifactorial unpleasant emotional experience of a psychological 
(cognitive, behavioural, emotional), social, and/or spiritual nature that may interfere 
with the ability to cope effectively with cancer, its physical symptoms and its 
treatment. Distress extends along a continuum, ranging from common normal 
feelings of vulnerability, sadness, and fears, to problems that can become disabling, 




Research shows that men with prostate cancer experience psychological distress 
(Balderson & Towell, 2003). There are many stages in the cancer journey where 
psychological distress can be experienced for men with prostate cancer (e.g. 
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diagnosis, decision making, treatment, recovery, survivorship) and research has 
shown that levels of distress experienced can fluctuate across these stages (Roth et 
al., 1998) perhaps due to psychological demands differing at each stage (Hsiao et 
al., 2011). Some studies indicate that psychological distress is lower in prostate 
cancer when compared to other cancers (Venderbos et al., 2015), perhaps due to 
its higher survival rate compared to other forms of cancer (Cancer Research UK 
Website, accessed 14/11/16). However, reviews have demonstrated mixed findings 
(Sharpley et al., 2008). The diversity of the findings might be explained by the way 
men display distress when they have prostate cancer. Mróz, Oliffe and Davison 
(2013) found that men with prostate cancer cope with the distress of having 
prostate cancer by using emotionally detached responses such as stoicism. Wall et 
al. (2013) conducted a qualitative study of men’s experiences of their first year post 
diagnosis. The authors found that following a period of overt distress, men used 
avoidance strategies to cope with further distress such as playing down the role of 
the psychological impact of having a diagnosis of prostate cancer. Blank & Bellizzi 
(2006) showed that the mixed results when looking at the levels of psychological 
distress in men who have survived prostate cancer may be due to the different 
coping styles used, with escapist coping style being negatively correlated with 
happiness and positive affect. Therefore, it may be that research is underestimating 
the level of distress associated with prostate cancer, due to men using strategies to 
avoid their distress. Further research combining data from many studies found that 
psychological distress is associated with increased risk of mortality with higher levels 
of psychological distress being associated with higher levels of mortality (Batty et 
al., 2017). This study found that this effect was true for prostate cancer even after 
elements such as age, education status, BMI, smoking and alcohol intake were 
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controlled for (Batty et al., 2017). This highlights the importance of establishing 
what factors are related to psychological distress in men with prostate cancer. 
 
Quality of Life 
Similarly, the findings related to QoL in individuals with prostate cancer seem to be 
mixed, fluctuating depending on stage of cancer journey (Jeldres et al., 2015; 
Drummond et al., 2015). Katz (2007) found that QoL is affected, regardless of type 
of active treatment. Specifically, it was found that the effect of prostate cancer 
treatment on a man’s sexual functioning had the most significant impact on their 
QoL (Katz, 2007). When looking across the whole cancer journey however, results 
are more mixed with certain stages of the prostate cancer journey being associated 
with lower QoL than others, for example, those who have undergone surgery tend 
to report lower QoL compared to those that are undergoing active surveillance 
(Jeldres et al., 2015). Poorer QoL is associated with aspects of psychological distress 
such as depression (Saini et al., 2013). 
 
Fear of Cancer Recurrence  
Individuals who have previously been diagnosed with prostate cancer or are 
currently diagnosed can suffer fear that this cancer will return (Mehta et al., 2003). 
FCR can be a burden to individuals with prostate cancer before and after treatment 
(Mehta et al., 2003). FCR has been assessed and identified across the prostate 
cancer journey, including before, during and after treatment (Hart et al., 2008).   
High levels of FCR has also been shown to be related to both poorer QoL and higher 
psychological distress (Hart et al., 2008; Bellizzi et al., 2008). As with QoL and 
psychological distress in prostate cancer, the level of fear of recurrence can differ 
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depending on treatment, with men undergoing surgery reporting greater FCR than 
those on active surveillance (Matthew et al., 2017). 
 
Psychological Flexibility 
Psychological Flexibility is an important part of psychological health and is defined 
by Kashdan (2010) as how well a person copes and adapts to varying psychological 
demands, applies mental resources flexibly, shifts their perspective depending on 
their context, and how well they balance competing demands on them. Kashdan 
(2010) also discusses Psychological Inflexibility in that it encompasses an individual 
who is at the other extreme of those elements of Psychological Flexibility and is 
characterised by an individual who is rigid, lacks sensitivity to context, and is 
inflexible in their thinking. Psychological Flexibility is the core mechanism of change 
in Acceptance and Commitment Therapy (ACT), a modern form of Cognitive 
Behavioural Therapy (Hayes et al., 2006). ACT proposes a model of influences on 
human behaviour that consists of six core processes that are overlapping and 
interdependent and together form Psychological Flexibility. These six processes are 
one side of the coin and each have a counterpart, and these counterparts together 
form the concept of Psychological Inflexibility (Figure 3.1) (Hayes et al., 2006). 
Newer research has suggested that this model could be grouped in to three 
overarching themes representing response styles of openness, awareness and 




Figure 3.1 – The ACT model of Psychological Flexibility/Inflexibility, two sides of the 
same coin, adapted from Luoma et al. (2007) 
 
Psychological Flexibility is associated with increased QoL, lower psychological 
distress and greater wellbeing (Kashdan & Rottenberg, 2010). This finding has been 
replicated in clinical health populations (McCracken & Velleman, 2010), but is less 
well researched in cancer populations. However, there is emerging evidence that 
targeting Psychological Flexibility when treating psychological distress in cancer 
patients might be a useful alternative to other types of psychological interventions 
(Hulbert-Williams et al., 2016). As discussed above there is evidence that men use 
avoidance strategies to cope with the emotional impact of prostate cancer (Mróz, 
Oliffe and Davison 2013; Wall et al., 2013), and avoidance is one of the six 
processes that contributes to Psychological Inflexibility. The literature assessing 
whether men with prostate cancer experience distress and poorer QoL as a 
consequence of their cancer is mixed, suggesting that another variable might be 
influencing when and how prostate cancer affects psychosocial outcomes. Given 
evidence that Psychological Inflexibility is associated with poorer mental health and 
wellbeing outcomes in general adult populations (Kashdan & Rottenberg, 2010), 
and researchers have suggested that it is worthy of further investigation in relation 
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to the psychological aspects of cancer management (Gundy et al., 2011), it is 
important to establish the role of Psychological Inflexibility on psychosocial 
outcomes in men with prostate cancer. Research has also started to assess whether 
Psychological Flexibility might mediate or moderate relationships between predictor 
and outcome variables. There is a previously established link between FCR and 
poorer psychosocial outcomes in prostate cancer. However, the mechanisms by 
which FCR affect these psychosocial outcomes are less clear. Recent research has 
suggested that Psychological Flexibility can also influence psychosocial outcomes in 
cancer patients, although this is less well evidenced within men with prostate 
cancer. Research looking at the use of ACT has suggested that Psychological 
Flexibility might act as a mechanism for change and this has been found to be the 
case with Psychological Flexibility acting as both a mediator (Wicksell et al., 2012) 
and a moderator (Oliver et al., 2011) in previous research. Previous research has 
alsso shown that although FCR and psychosocial outcomes are correlated, they are 
not perfectly correlated, even when other variables such as treatment stage and 
treatment type (Mehta et al., 2003) are taken into account. This suggests that other 
variables remain to be identified and added to this model. Psychological flexibility 
has been investigated as a mechanism of change previously, and previous reviews 
(Hulbert-Williams et al., 2016) have suggested that greater theory building around 
how and when psychological flexibility affects psychosocial outcomes is required. 
Given a lack of previous research in this area, and that psychological flexibility has 
been conceptualised as both a mediator and a moderator previously, it is important 
to assess whether the data provides evidence for either scenario as the theory is not 





Despite limited research looking at the impact of Psychological Flexibility and 
inflexibility on cancer populations, recent papers have argued for a role of 
Psychological Flexibility on psychological distress in cancer patients (e.g. Hulbert-
Williams et al., 2016). The impact of having prostate cancer on psychosocial 
outcomes is also not clear, and authors have suggested that differences within the 
prostate cancer population around coping styles, or treatment stage might explain 
some of the differences in findings. Therefore, the current study aims to investigate 
the role of Psychological Flexibility on psychological distress and QoL in men with 
prostate cancer. It will also investigate the role of FCR in QoL and distress and 
whether Psychological Flexibility might act as a mediator or a moderator in this 
relationship. This is with the goal of discovering what role Psychological Flexibility 
plays for men with prostate cancer and potentially providing further rationale for the 
use of ACT in this population. 
 
Materials and Methods 
 
Design 
This study employed a cross-sectional online survey-based design. Participants 
completed quantitative measures of Psychological Flexibility, FCR, psychological 
distress, QoL and were asked to provide relevant demographic information. Ethical 
approval was obtained from both the University of Edinburgh School of Health in 
Social Science, and from the United Kingdom National Health Service Integrated 





Participants were eligible if they currently had a diagnosis of prostate cancer or had 
previously been diagnosed with prostate cancer. Participant data was excluded if 
they indicated that either they did not have a diagnosis of prostate cancer (at which 
point the survey would end) or if they indicated that they received this diagnosis 
from a source other than an appropriate clinician. 
 
Measures 
The survey gathered data on relevant demographic information including treatment 
type, time since diagnosis, age, previous or current support for cancer related 
distress and country of residence. Standardised questionnaires measuring the 
following constructs were also used (see Appendix 3.B for full details of the survey). 
Psychological Flexibility 
Despite measures of psychological flexibility being employed in a cancer population 
previously (Montiel et al., 2016), the above review did not identify any measures 
that had been specifically validated in a cancer population, nor any measures of 
psychological flexibility that had been adequately validated in a health population in 
English. Despite the AAQ-II being previously used as a measure of psychological 
flexibility in research using cancer patients (e.g. Montiel et al., 2016), recent 
criticisms of this measure have identified that this scale may in fact be measuring a 
broader concept than psychological flexibility such as neuroticism (Rochefort et al., 
2017). Therefore, this study measured psychological flexibility using the 
Comprehensive assessment of Acceptance and Commitment Therapy processes 
(CompACT: Francis et al., 2016). Although this is a newer measure, it has been 
shown to have good internal consistency and that it has a stable three factor 
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structure, better aligning with the ACT model of psychopathology (Francis et al., 
2016).  
Quality of Life (QoL) 
This was measured using the Patient Orientated Prostate Utility Scale (PORPUS: 
Krahn et al., 2000). A review of measures used to assess QoL in individuals with 
prostate cancer highlighted four measures that were high quality, one of which was 
the PORPUS (Schmidt et al., 2014). The PORPUS was the only one of these four 
designed for use with individuals with prostate cancer at all stages of the disease 
(the other three being designed for use in early stage only). Test–retest reliability 
for the PORPUS as a psychometric instrument ranged from 0.79 to 0.81 and 
construct validity has been demonstrated (Ritvo et al., 2005). The PORPUS is ten 
items. The PORPUS gives a global QoL score out of 100 with higher scores 
indicating greater QoL.  
Psychological Distress  
Psychological Distress was measured using the Depression Anxiety Stress Scales – 
21 item (DASS-21: Lovibond & Lovibond, 1995; Henry & Crawford, 2005). The 
DASS-21 measures common symptoms of depression, anxiety and stress. It has 
been shown to validly measure all three aspects, whilst also providing an overall 
measure of psychological distress. It is known to have good internal consistency 
(=.82-94) across several samples, and concurrent validity with other measures of 
distress (Anthony et al., 1998).  
Fear of Recurrence (FCR) 
This was measured by a new measure, the Fear of Cancer Recurrence Scale (FCR7: 
Humphries et al., 2018). This seven-item scale focuses on the anxiety or fear 
related to FCR and provides a total score of FCR in individuals with cancer. It has 
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adequate internal consistency ( = 0.90) and validity has been investigated 
(Humphries et al., 2018). Despite the recent publication of this measure, it has been 
used by researchers with a range of cancer types and in a number of clinical 
settings previously, albeit under the name ‘Fear of Recurrence Scale’ (FCR7: e.g.  
Simard et al., 2013; Rogers et al., 2010). Although this measure has not been 
explicitly used in a prostate cancer population, measures of FCR have been used 
with men with prostate cancer across the treatment journey including before, during 
and after treatment (e.g. Mehta et al., 2003). 
 
Recruitment 
Participants were men diagnosed with prostate cancer, however they did not need 
to currently be in an active phase of illness. Individuals were recruited through a 
variety of sources. Posters and business cards that advertised the study and gave 
information on how to take part were located in clinical areas such as general 
practice surgeries, Maggie’s cancer centres, churches and cancer treatment centre 
waiting rooms. Cancer clinicians, including oncologists and specialist cancer nurses 
were provided with information to give out to potential participants that they came 
in to contact with. As this was a multisite study, clinicians from across Scotland 
were contacted regarding the survey. Sites in Glasgow, Aberdeen and Fife agreed to 
host the study and advertise the survey through their clinical services. Other 
services (such as cancer charities and Maggie’s centres) across the United Kingdom 
and Ireland also agreed to assist with advertising the study, for example multiple 
Maggie’s centres in England, Scotland and Wales and charities in Ireland all agreed 
to advertise the survey. Online recruitment was undertaken via online support 
networks, Facebook groups, twitter and through a website specifically designed to 
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advertise the study. This was with the aim of making the survey accessible to as 
wide a variety of individuals from as many geographical areas as possible.  
 
Individuals recruited to the study accessed an online survey hosted by the Bristol 
Online Survey Tool. Individuals were prompted to give consent to the study (and 
any who did not give consent were taken to the last page of the survey) and were 
prompted to confirm that they had a diagnosis of prostate cancer. 147 individuals 
completed the survey, three indicated that they did not have a diagnosis of prostate 




Missing data was investigated using SPSS’s missing data analysis function at the 
individual item level to determine if there was any pattern in missing data for a 
specific item. Investigation of the output revealed very little missing data (the 
largest item for missing data was age which had 10.40% of missing data) and no 
clear patterns to the missing data, which was confirmed by Little’s MCAR test being 
non-significant, suggesting that the data was missing completely at random; 
X2=2115.99(df=2156), p=.727. Following this, missing data was imputed using an 
expectation maximisation method as this has been shown to be appropriate with 
data that is missing at random and missing completely at random (Enders, 2011). It 
should be noted that the total score for the PORPUS is calculated with a formula 
that allows for individual’s to have missed up to two items. Therefore, this formula 
was used, and as no participants missed more than two items, no data required to 






The data was investigated to assess whether it met assumptions required for 
parametric analysis. The data was ordinal, was gathered in a way that it was 
possible to assume independence of observations and that it met the assumption of 
related pairs. Histograms for each variable were investigated to confirm normal 
distribution. For each of the regressions, scatterplots were investigated and these 
confirmed that the relationships between the variables were linear and that the 
variability was similar for each variable suggesting that the assumptions of linearity 
and homoscedasticity were not violated. Multicollinearity was assessed for each 
analysis by investigation of tolerance and Variance Inflation Factor (VIF). This 
revealed, for all analyses, tolerance was above .10 and VIF was below 10 
suggesting that the multicollinearity assumption had not been violated according to 
guidelines suggested by Pallant (2010). 
 
Main Analyses 
The data was analysed using IBM SPSS Statistics 24. Descriptive statistics, covariate 
analysis and correlations were undertaken. Multiple regression analysis, using a 
forced entry method was used to compare the strength of association between each 
of the predictor variables and the dependent variables simultaneously, as outlined 
by Gillanders et al. (2015). Whilst regression can compare strength of association 
between multiple variables simultaneously, it cannot model complex interplay 
between variables in arriving at outcomes. For this reason, conditional process 
analysis was conducted to investigate moderation and mediation effects. Hayes’ 
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(2013) PROCESS tool was used to assess whether Psychological Flexibility acts as a 
mediator or a moderator between FCR and the outcome variables, using the 
bootstrapped product of coefficient’s approach. 
 
Sample size 
Sample size was calculated a priori using the G*Power programme (Faul et al., 
2007). Research assessing correlations between FCR and psychosocial outcomes in 
men with prostate cancer have identified medium effects (e.g. Hart et al., 2008). 
Despite a lack of research assessing correlations between Psychological Flexibility 
and psychosocial outcomes in men with prostate cancer, research looking at other 
cancer types or mixed cancer samples have identified medium to large effect sizes 
(e.g. Hulbert-Williams & Storey, 2016). Therefore, sample size was calculated based 
on the ability to detect medium sized effects and larger (f=0.15) and power was set 
at 0.80. Alpha level was set at 0.05. This research aims to establish how well seven 
predictors (Psychological Flexibility, FCR, treatment type, time since diagnosed, age, 
current or past psychological support for cancer related distress and country of 
residence) affect two different outcome variables (QoL and psychological distress). 




It was hypothesised that the key predictor and outcome variables would be 
correlated with each other and that the predictor variables (Psychological Flexibility 
and FCR) would each explain statistically significant proportions of the variance in 
each of the outcome variables (psychological distress and QoL). Research suggests 
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that FCR is related to poorer psychosocial outcomes, and that Psychological 
Flexibility has been shown to act as a mediator and a moderator in other clinical 
samples. To investigate whether Psychological Flexibility acting as a moderator or a 
mediator best fits the data will be assessed with two hypotheses that Psychological 
Flexibility will act as a mediator (as in Figure 3.2) and that it will act as a moderator 
(as in Figure 3.3) between FCR and the outcome variables. 
 
     
Figure 3.2 Psychological Flexibility as a mediator between fear of cancer recurrence 
and outcome variables psychological distress and QoL. 
 
      
Figure 3.3 Psychological Flexibility as a moderator between fear of cancer 









Sample characteristics on the demographic items can be found in Table 3.1 along 
with normative data. This indicates that this sample is similar to United Kingdom 
(UK) normative data on most of the demographic variables with the exception of 
treatment and country of residence. Regarding country of residence, a higher 
proportion of participants were resident in Scotland than might be expected given 
the UK normative data. This sample also held a higher proportion of individuals on 
active treatments (surgery and other active, non-surgery treatments). Table 3.2 
demonstrates descriptive statistics for this sample of the main predictor and 
outcome variables compared to normative data. This revealed that the current 
sample is similar to normative data although contained individuals that reported 
slightly lower levels of FCR and higher levels of distress than has been found in 














 Range Mean (SD) 
Normative Data 
Mode (%) 
Age 43-87 68.5 (7.2) 40-69 (56.7)1 
Years since diagnosis 1-26 6.0 (4.13) 1-5 (38.0)1 
  N (%) 
Normative Data 
% 
Country resident in UK (England) 91 (63.2) 85.01 
UK (Scotland) 46 (31.9) 7.01 
UK (Wales) 6 (4.2) 5.51 
Ireland 1 (0.7) 
 
- 
Previous or current 
psychological support 
No 125 (86.8) - 
Yes 17 (11.8) - 
Don’t Know 2 (1.4) 
 
- 
Treatment Surgery 63 (43.8) 14.92 
Active, not surgery 76 (52.8) 33.0*2 
Non-active 5 (3.5) - 
*statistics available for radiotherapy and chemotherapy only; -data not available; 
1National Cancer Registration and Analysis Service website, Accessed April 2018; 
2Cancer Research UK Website, Accessed April 2018 





Min Max Mean SD 
Normative Data 
Mean SD 
Predictor Variables        
compACT 0-138 31.00 135.00 68.47 6.79 95.041 15.781 
FCR7 5-35 7.00 34.00 15.88 6.47 18.652 - 
Outcome Variables        
DASS 0-42 00.00 39.33 8.03 8.23 5.663 7.743 
QoL 1-100 21.33 95.00 65.05 15.82 69.604 11.704 
1Gillanders et al. (in preparation); 2Rogers et al. (2010); 3Henry & Crawford (2005); 
4Bremner et al. (2007). 
Table 3.2 descriptive statistics of key predictor and outcome variables.  
 
Covariate Analysis 
We gathered data on variables (such as treatment type, age, years since diagnosis) 
that have previously been shown to impact on the outcome variables. We initially 
entered these variables as control variables, however these did not significantly 
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predict any of the variance in our outcome variables in our sample and therefore 
they were removed from the analysis in order to preserve power. 
 
Correlation Analysis 
Correlation analyses were conducted to assess how related the variables were with 
each other. This revealed that all variables were significantly correlated with each 
other (Table 3.3). Correlations were medium with the exception of the correlations 
between the compACT and the DASS and the DASS and the PORPUS which were 
large (according to Cohen’s 1988 guidelines). 
 
Variable compACT FCR7 DASS PORPUS 
compACT -    
FCR7 -.40* -   
DASS -.67** .48** -  
PORPUS .37** -.49** -.53** - 
**p<.001 (2-tailed) 
Table 3.3 – correlation analysis for all variables. 
 
Regression analysis 
Regression analyses revealed that the FCR7 and the compACT as a whole explained 
49% of the variance in the DASS, AdjR2=.49, F(2,141)=69.67, p<.0001, with the 
compACT making a larger contribution to the variance of the DASS than the FCR7 
(Table 3.4). The FCR7 and the compACT as a whole explain 26% of the variance of 
the PORPUS, AdjR2=.26, F(2,141)=26.53, p<.0001. FCR7 was a stronger predictor of 






Variables β t p R2 Adj R2 F(2,141) p 
Dependent Variable: 
DASS 
   .50 .49 69.67 <.0001 
compACT -.56 -8.66 <.0001     
FCR7 .25 3.90 <.0001     
Dependent Variable: 
PORPUS 
   .27 .26 26.53 <.0001 
compACT .21 2.64 <.0001     
FCR7 -.41 -5.17 <.0001     
Table 3.4 – Linear regression for the prediction of two dependent variables, DASS 
and PORPUS. 
 
Conditional Process Analysis 
Psychological Flexibility as a mediator 
There was a significant indirect effect of FCR on psychological distress via 
Psychological Flexibility, b=.29, BCa CI [.16, .42] (Figure 3.4). The model as a 
whole explained 50% of the variance in psychological distress, R2=.50, 
F(2,141)=69.67, p<.0001, which is 26% more than the variance explained by FCR 
alone, R2=.23, F(1,142)=42.35, p<.0001. There was also a significant indirect effect of 
FCR on QoL through Psychological Flexibility, b=-.20m BCa CI [-.38, -.06] (Figure 
3.5). The total model explained 27% of the variance in QoL, R2=.27, F(2,141)=26.53, 
p<.0001, whereas the total effect of FCR on QoL alone explained 24% of the 





Path b LLCI ULCI 
Direct (FCR to Psych Distress) .32 .16 .49 
Indirect (via Psych Flex) .29 .16 .42 
FCR to Psych Flex -1.22 -1.69 -.76 
Psych Flex to Psych Distress -.23 -.29 -.18 
Model Summary: R2=.50, F(2,141)=69.67, p<.0001 
Total Effect Model: R2=.23, F(1,142)=42.35, P<.0001 
 
**p<.0001. LLCI (Lower Level Confidence Interval), ULCI (Upper Level Confidence 
Interval). 
Figure 3.4 – Psychological Flexibility (Psych Flex) as a mediator between Fear of 









Path b LLCI ULCI 
Direct (FCR to QoL) -.99 -1.37 -.61 
Indirect (via Psych Flex) -.20 -.38 -.06 
FCR to Psych Flex -1.22 -1.69 -.76 
Psych Flex to QoL .16 .04 .29 
Model Summary: R2=.27, F(2,141)=26.53, p<.0001 
Total Effect Model: R2=.24, F(1,142)=44.26, p<.0001 
**p<.0001, *P<.05. LLCI (Lower Level Confidence Interval), ULCI (Upper Level 
Confidence Interval). 
Figure 3.5 – Psychological Flexibility (Psych Flex) as a mediator between Fear of 
Cancer Recurrence (FCR) and Quality of Life (QoL). 
 
Psychological Flexibility as a moderator 
Moderation analysis revealed that Psychological Flexibility did not significantly 
moderate the relationship between FCR and QoL, b=.00, 95% CI [-.01-.02], t=.61, 
p=.54 (Figure 3.7). Psychological Flexibility was shown to moderate the relationship 
between FCR and psychological distress, b=-.01, 95% CI [-.02, -.01], t=-3.74, 
p<.001 (Figure 3.6). Further investigation of this moderating effect revealed that at 
low levels of Psychological Flexibility there is a significant, positive relationship 
between FCR and psychological distress, b=.45, 95% CI [.28, .62], t=5.24, 
p<.0001. However, at high levels of Psychological Flexibility, this relationship 
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between FCR and psychological distress is no longer significant, b=-.01, 95% CI [-


















.03 -8.57 <.0001 
FCR x Psych Flex 
-.01 
(-.02,-.01) 
.00 -3.74 <.001 
R2=.54, F(3,140)=55.37, P<.0001 
Figure 3.6 – Psychological Flexibility (Psych Flex) as a moderator between Fear of 






















.06 2.54 <.05 
FCR x Psych Flex 
.00 
(-.01,.02) 
.01 .61 =.541 
R2=.28, F(3,140)=17.73, p<.0001 
Figure 3.7 – Psychological Flexibility (Psych Flex) as a moderator between Fear of 




This study found that both as a whole, and individually, Psychological Flexibility and 
FCR significantly explained variance in both psychological distress and QoL. 
Psychological Flexibility was found to mediate the relationship between FCR and 
QoL and FCR and psychological distress. Psychological Flexibility acted as a 







Simple correlations of the predictor and outcome variables demonstrated that all the 
concepts under investigation are correlated with each other. This highlights the 
interconnectedness of these concepts for men with prostate cancer. Previous 
research looking at these concepts has shown that they are related (Hart et al., 
2008; Bellizzi et al., 2008; McCracken & Velleman, 2010) in individuals with cancer 
or other clinical populations, however, this has not been confirmed for men with 
prostate cancer previously.  
 
Regression Analyses 
Psychological Flexibility was shown to uniquely predict statistically significant 
variance in both psychological distress and QoL. Psychological Flexibility predicted 
more variance in psychological distress than in QoL; if scores on the measure of 
Psychological Flexibility were to increase by one SD, scores on the measure of 
psychological distress would increase by over half a SD, whereas scores on the QoL 
measure would increase by just under a quarter of a SD. ACT, which aims to 
increase a person’s ability to be psychologically flexible, does not directly aim to 
change the distress that an individual is feeling, rather it aims to increase the ability 
of a person to be able to live a life more fully in line with their values whilst 
accepting unwanted thoughts, feelings and sensations (Ciarrochi et al., 2010). 
Despite this, many studies do conclude that Psychological Flexibility increases and 
psychological distress decreases following ACT for cancer patients (Montiel et al., 
2016), and that Psychological Flexibility is negatively correlated with psychological 
distress in other populations (McCracken & Velleman, 2010). Previous research 
looking at a diverse cancer population that included some men with prostate cancer 
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concluded that QoL and Psychological Flexibility were significantly correlated, and 
that Psychological Flexibility explained some unique variance in QoL, even once the 
effect of demographic variables and other outcome variables were taken into 
account (Hulbert-Williams & Storey, 2016). However, to the authors’ knowledge, no 
research has explicitly investigated the role of Psychological Flexibility in the levels 
of psychological distress and QoL experienced by men with prostate cancer. 
 
This study also found that FCR uniquely predicts statistically significant variance in 
both psychological distress and QoL. However, FCR is a stronger unique predictor of 
the variance in QoL compared to Psychological Flexibility and predicts less of the 
variance in psychological distress than Psychological Flexibility. This finding is line 
with previous research conducted in men who have been diagnosed with prostate 
cancer which demonstrated that FCR is associated with higher levels of 
psychological distress and lower levels of QoL (van de Wal et al., 2016). 
 
Psychological Flexibility as a Mediator 
Psychological Flexibility was found to mediate the relationship between FCR and 
QoL and FCR and psychological distress. Previous research in other clinical areas 
has assessed Psychological Flexibility as a mediator (e.g. Wicksell et al., 2012) and 
found that it can be conceptualised as this. Previous research has demonstrated 
that FCR is correlated with QoL and psychological distress (van de Wal et al., 2016), 
and this research extends these findings by demonstrating that, in men with 
prostate cancer, Psychological Flexibility mediates these relationships. Future 
research might attempt to establish whether this pattern of results is applicable in 
other cancer diagnoses. The results in this study suggest that by targeting 
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Psychological Flexibility we may be able to reduce psychological distress or increase 
QoL. The results show that by adding Psychological Flexibility to the model, this 
increases the overall variance explained in psychological distress more than it 
increases the overall variance explained in QoL. This suggests that targeting 
Psychological Flexibility may have more of a direct impact on psychological distress 
than on QoL. 
 
Psychological Flexibility as a Moderator 
Psychological Flexibility has been shown to act as a moderator in other clinical 
samples (e.g. Oliver et al., 2011), and this study furthered such research by 
demonstrating that Psychological Flexibility acts as a moderator between FCR and 
psychological distress. FCR only significantly predicted distress when Psychological 
Flexibility was at low or average levels, but not when Psychological Flexibility was 
high. This suggests that high levels of Psychological Flexibility may act as a 
protective factor against FCR resulting in less psychological distress for men with 
prostate cancer. This may provide further evidence for the use of therapies such as 
ACT in this population, as directly targeting Psychological Flexibility may protect 
against psychological distress associated with cancer specific constructs such as 
FCR. Although there is no previous literature looking at the relationship between 
FCR and Psychological Flexibility for men with prostate cancer, authors have 
suggested that, for conceptual reasons, Psychological Flexibility might be linked with 
FCR in cancer patients, with Psychological Flexibility acting as a protective factor 
against the development of high levels of FCR (Fardell et al., 2016). Studies have 
shown that health professionals in cancer settings use elements of ACT to help 
patients manage levels of FCR (Thewes et al., 2014). This research suggests that in 
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addition to these strategies that help an individual to reduce FCR, it might also be 
possible for an individual to be supported to behave in a more flexible way in 
response to their FCR in order to reduce its psychosocial impact.  
 
Limitations 
This research has several limitations. As it is cross-sectional in nature, all data was 
taken at a single timepoint, meaning causality is not demonstrated. Future research 
could look at whether interventions, such as ACT, which aim to increase 
Psychological Flexibility, can result in a change in psychological distress or QoL in 
order to begin to provide some evidence for a causal link between elements such as 
Psychological Flexibility and psychological distress. This study was advertised widely, 
using an a priori plan, however, there is potential that the way it was advertised 
may have biased the sample. For example, marketing was partly done through 
support networks and social media, and therefore individuals who are actively 
seeking or engaging with social support may have been more likely to have seen 
the advert for the study. Although this study also advertised through clinical 
settings, we have no data on where individuals who took part in the study saw it 
advertised. If this study were run again, an additional question in the survey asking 
where individuals heard about the survey would help in deciding whether the 
sample was biased towards those seeking social support. The current sample also 
contained a higher percentage of individuals from Scotland than would be expected 
given population norms for the numbers of individuals diagnosed with prostate 
cancer in each UK country. Although the research aimed to recruit from across the 
UK, the study was based in Scotland and therefore it is not unexpected that a 
higher proportion of participants came from Scotland. However, this may have 
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implications for the generalisability of the study.  Due to the online nature of this 
survey, individuals would have required some computer literacy to take part. The 
survey nature and the time taken to complete it, although not overly onerous, may 
have resulted in individuals who were more unwell with prostate cancer not being 
able to take part. It was also not possible to gather data on individuals who saw the 
study advertised but chose not to take part. A higher proportion of individuals than 
would be expected compared to population norms were in active treatment, and 
therefore, the findings may not extend to those who are on active surveillance or 
watchful waiting. Future research could focus on these populations to establish 




Research has shown that psychosocial outcomes can impact on mortality rates in 
men with prostate cancer (Batty et al., 2017). This research suggests that 
psychological flexibility is also related to psychosocial outcomes, and future research 
could assess whether there is any link between low levels of psychological flexibility 
and mortality rates in this population. Research has shown that ACT can improve 
outcomes for individuals with cancer (Feros et al., 2011). The current research 
supports the rationale that the use of therapies such as ACT that aim to increase 
Psychological Flexibility may have an impact on the levels of psychological distress 
experienced by individuals with prostate cancer, their quality of life and ameliorate 
the impact of FCR on psychosocial outcomes. Future research could begin to extend 
this finding by evaluating the use of ACT in this population, in order to attempt to 
demonstrate a causal link between Psychological Flexibility and distress or QoL, 
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beyond the correlational link demonstrated in this study. Researchers have 
suggested that interventions that specifically target FCR need to be assessed and 
that existing interventions appear to be based mostly on cognitive behavioural 
therapy (Lebel et al., 2017). The current research suggests that whilst FCR is 
associated with distress and QoL, Psychological Flexibility may have more value as a 
therapeutic target as it has the potential to act both as a mediator between FCR and 
negative psychosocial outcomes and as a protective factor against developing 
distress and poorer QoL. Future research might therefore focus on the use of ACT in 
cancer populations and whether this can result in the reduction of the impact of 
FCR, rather than attempts to directly change or control FCR. Psychological Flexibility 
and FCR explained less of the overall variance in QoL compared to the variance 
explained in psychological distress. This suggests that additional variables are 
influencing QoL in men with prostate cancer and future research could investigate 
what other variables affect QoL in this population. The current research used a 
prostate cancer population, and future research could replicate this study in other 




This research has implications for clinical practice. Firstly, it provides further 
evidence that Psychological Flexibility is related to psychosocial outcomes including 
distress and QoL in cancer patients and provides initial evidence specifically for men 
with prostate cancer. This suggests that ACT based treatments which aim to 
increase Psychological Flexibility may be of use in men with prostate cancer 
specifically, and perhaps in cancer patients more widely, who are struggling with the 
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psychosocial impact of cancer. Secondly, it provides evidence that Psychological 
Flexibility acts as both a mediator and moderator of the relationship between FCR 
and psychological distress and as a mediator between FCR and QoL. This provides 
evidence for the wide-reaching nature of the concept of Psychological Flexibility 
within this population and suggests useful interventions might focus on increasing 
levels of Psychological Flexibility in this population. As the relationship between FCR 
and psychological distress was significant at lower levels of Psychological Flexibility, 
this suggests that Psychological Flexibility can act as a protective factor in men with 
prostate cancer. Therefore, identification of Psychological Flexibility in men with 
prostate cancer early in their cancer journey might be helpful in order to target 
those with lower levels of Psychological Flexibility. Screening measures of 
Psychological Flexibility that are appropriate and valid in this population might be 
employed through cancer nurse specialists or at entry points to services. It might 
also be useful for all those who work with men with prostate cancer to have an 
understanding of Psychological Flexibility and its impact in order for psychosocial 
difficulties to be identified early. Low level interventions that aim to increase levels 
of Psychological Flexibility that could be delivered by healthcare professionals not 
trained specifically in ACT might increase the availability of these interventions. This 
may help to increase levels of Psychological Flexibility across the population of those 
with prostate cancer, without the need for a large increase in resources. It may also 
have the secondary impact of reducing the need for more specialised clinical 







This research has demonstrated that Psychological Flexibility impacts distress and 
QoL directly and via mediating and moderating the effect of FCR. Identifying 
predictors of poor psychosocial outcomes in men with prostate cancer that are 
targetable with existing interventions such as ACT is not only important to improve 
the lives of men with prostate cancer but also to potentially reduce mortality rates 
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The Journal of Contextual Behavioral Science is the official journal of the Association for Contextual
Behavioral Science (ACBS).
Contextual Behavioral Science is a systematic and pragmatic approach to the understanding of
behavior, the solution of human problems, and the promotion of human growth and development.
Contextual Behavioral Science uses functional principles and theories to analyze and modify action
embedded in its historical and situational context. The goal is to predict and influence behavior,
with precision, scope, and depth, across all behavioral domains and all levels of analysis, so as to
help create a behavioral science that is more adequate to the challenge of the human condition.
Contextual behavioral science is a strategic approach to the analysis of human behavior that proposes
the need for a multi-level (e.g. social factors, neurological factors, behavioral factors) and multi-
method (e.g., time series analyses, cross-sectional, experimental) exploration of contextual and
manipulable variables relevant to the prediction and influence of human behavior.
The journal considers papers relevant to a contextual behavioral approach including: Empirical studies
(without topical restriction - e.g., clinical psychology, psychopathology, education, organizational
psychology, etc.) Brief reports on preliminary, but provocative findings Reviews (systematic reviews
and meta-analyses are preferred) and Conceptual and philosophical papers on contextual behavioral
science
We are particularly interested in: Papers emphasizing the study of core behavioral processes
that are relevant to a broad range of human problems Papers bridging different approaches
(e.g., connecting behavioral approaches with cognitive views; or neurocognitive psychology; or
evolutionary science) Papers that challenge a contextual behavioral science approach from an
informed perspective
The journal welcomes papers written by researchers, practitioners, and theoreticians from different
intellectual traditions. What is distinctive is not a narrowly defined theory or set of applied methods
but whether the methodology, conceptualization, or strategy employed is relevant to a contextual
behavioral approach.
Special Issues
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(specific titles or general areas), a proposed timeline for submission, peer-reviewing, revision and
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All manuscripts must clearly and explicitly be of relevance to CBS. You may find the JCBS article
"Contextual Behavioral Science: creating a science more adequate to the challenge of the human
condition" helpful in assessing whether your manuscript is likely to be of interest to readers of this
journal.
Articles should fall into one of seven categories:
1. Empirical research (up to 6000 words)
2. Brief empirical reports (up to 3000 words)
3. Review articles (up to 10,000 words)
4. Conceptual articles (up to 6000 words)
5. In practice (up to 3000 words)
6. Practical innovations (up to 3000 words)
7. Professional interest briefs (up to 3000 words)
Word limits exclude references, tables and figures but include the abstract
1. Empirical research. JCBS welcomes manuscripts across a breadth of domains from basic behavioral
science to clinical trials. Research concerning the measurement and testing of process of change is
particularly welcome. Potential methodologies include but are not limited to: randomized controlled
trials, single case experimental designs, cross-sectional and prospective cohort studies, mixed-
methods designs, small scale analog studies. Papers reporting null findings are also welcome if their
methodology is sound and their power sufficient. Authors of such papers will need to emphasize the
implications of their findings for future research and practice.
2. Brief empirical reports. Manuscripts in this section may report preliminary, provocative or replicated
results. Empirically sound methodology and adequate power remain important considerations.
3. Review articles. Manuscripts reviewing a wide range of topics are encouraged as long as their
content is directly relevant to CBS. Systematic reviews and meta-analyses are particularly welcome.
Authors are advised to consult relevant MARS (http://www.apa.org/pubs/authors/jars.pdf) and
PRISMA resources (http://www.prisma-statement.org/) when preparing such manuscripts.
4. Conceptual articles. Manuscripts in this section should address conceptual or theoretical issues
relevant to CBS. This may include papers that discuss relevant philosophical assumptions and
traditions, or conceptual papers which explore aspects of or inconsistencies in contextual behavioral
theory and science.
5. In practice. Manuscripts in this section are designed to make CBS useful to practitioners from
a wide variety of areas. Manuscripts must be written in an accessible style and should be easily
understood by practitioners who are not experts in research or basic behavioral science. Manuscripts
should provide both clear insights for new practitioners as well as stating the questions that remain
to be answered by future research.
6. Practical innovations. Manuscripts in this section seek to apply the findings and applications of CBS
to under-studied, under-served or novel areas. The scope of these manuscripts is limited only by the
journal's broad mission: creating a science more adequate to the challenge of the human condition.
7. Professional interest briefs. Manuscripts in this section highlight professional issues of relevance to
those working in the field of CBS. Examples include manuscripts related to training and supervision,
assessment methods in professional settings or opinions on contemporary issues.
The Journal welcomes suggestions for Special Issues. Proposals for a themed Special Issue should be
sent to the Editor-in-Chief, Emily Sandoz at emilysandoz@louisiana.edu, and should include suggested
Executive, Advisory or Guest Editors, a proposed call-for-papers, 6-10 provisional authors and topics
(specific titles or general areas), a proposed timeline for submission, peer-reviewing, revision and
publication. All manuscripts in a special issue will be subject to the normal process of peer-review.
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Contact details for submission
To contact the Editor-in-Chief prior to your submission with any questions, please email
emilysandoz@louisiana.edu
Submission checklist
You can use this list to carry out a final check of your submission before you send it to the journal for
review. Please check the relevant section in this Guide for Authors for more details.
Ensure that the following items are present:
One author has been designated as the corresponding author with contact details:
• E-mail address
• Full postal address
All necessary files have been uploaded:
Manuscript:
• Include keywords
• All figures (include relevant captions)
• All tables (including titles, description, footnotes)
• Ensure all figure and table citations in the text match the files provided
• Indicate clearly if color should be used for any figures in print
Graphical Abstracts / Highlights files (where applicable)
Supplemental files (where applicable)
Further considerations
• Manuscript has been 'spell checked' and 'grammar checked'
• All references mentioned in the Reference List are cited in the text, and vice versa
• Permission has been obtained for use of copyrighted material from other sources (including the
Internet)
• A competing interests statement is provided, even if the authors have no competing interests to
declare
• Journal policies detailed in this guide have been reviewed
• Referee suggestions and contact details provided, based on journal requirements
For further information, visit our Support Center.
BEFORE YOU BEGIN
Authors should prepare their manuscript for double-blind review, so that only the handling editors
have access to author details. Authors must take special care to delete all potentially identifying
information from any files that are not the Title Page with author details and the Cover Letter.
Note: these two documents are submitted separately to the main manuscript. Any potential author
identifying information including, but not limited to, name(s), affiliation(s), geographic location(s),
identifying acknowledgments, author notes, or funding details, should be removed from all other files.
For authors resubmitting revisions of manuscripts, please ensure that the "Response to reviewers" is
also free from author identifying information. Manuscripts that are not appropriately blinded will be
rejected without a full content review, although in many cases authors will be invited to re-submit
manuscripts without author identifying information. This process will, however, delay review and
manuscript processing times and should be avoided if at all possible.
Ethics in publishing
Please see our information pages on Ethics in publishing and Ethical guidelines for journal publication.
Human and animal rights
If the work involves the use of human subjects, the author should ensure that the work described has
been carried out in accordance with The Code of Ethics of the World Medical Association (Declaration
of Helsinki) for experiments involving humans; Uniform Requirements for manuscripts submitted to
Biomedical journals. Authors should include a statement in the manuscript that informed consent
was obtained for experimentation with human subjects. The privacy rights of human subjects must
always be observed.
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All animal experiments should comply with the ARRIVE guidelines and should be carried out in
accordance with the U.K. Animals (Scientific Procedures) Act, 1986 and associated guidelines, EU
Directive 2010/63/EU for animal experiments, or the National Institutes of Health guide for the care
and use of Laboratory animals (NIH Publications No. 8023, revised 1978) and the authors should
clearly indicate in the manuscript that such guidelines have been followed.
Declaration of interest
All authors must disclose any financial and personal relationships with other people or organizations
that could inappropriately influence (bias) their work. Examples of potential conflicts of interest include
employment, consultancies, stock ownership, honoraria, paid expert testimony, patent applications/
registrations, and grants or other funding. Authors must disclose any interests in two places: 1. A
summary declaration of interest statement in the title page file (if double-blind) or the manuscript file
(if single-blind). If there are no interests to declare then please state this: 'Declarations of interest:
none'. This summary statement will be ultimately published if the article is accepted. 2. Detailed
disclosures as part of a separate Declaration of Interest form, which forms part of the journal's official
records. It is important for potential interests to be declared in both places and that the information
matches. More information.
Submission declaration and verification
Submission of an article implies that the work described has not been published previously (except in
the form of an abstract, a published lecture or academic thesis, see 'Multiple, redundant or concurrent
publication' for more information), that it is not under consideration for publication elsewhere, that
its publication is approved by all authors and tacitly or explicitly by the responsible authorities where
the work was carried out, and that, if accepted, it will not be published elsewhere in the same form, in
English or in any other language, including electronically without the written consent of the copyright-
holder. To verify originality, your article may be checked by the originality detection service Crossref
Similarity Check.
Preprints
Please note that preprints can be shared anywhere at any time, in line with Elsevier's sharing policy.
Sharing your preprints e.g. on a preprint server will not count as prior publication (see 'Multiple,
redundant or concurrent publication' for more information).
Authorship
All authors should have made substantial contributions to all of the following: (1) the conception and
design of the study, or acquisition of data, or analysis and interpretation of data, (2) drafting the
article or revising it critically for important intellectual content, (3) final approval of the version to
be submitted.
Changes to authorship
Authors are expected to consider carefully the list and order of authors before submitting their
manuscript and provide the definitive list of authors at the time of the original submission. Any
addition, deletion or rearrangement of author names in the authorship list should be made only
before the manuscript has been accepted and only if approved by the journal Editor. To request such
a change, the Editor must receive the following from the corresponding author: (a) the reason
for the change in author list and (b) written confirmation (e-mail, letter) from all authors that they
agree with the addition, removal or rearrangement. In the case of addition or removal of authors,
this includes confirmation from the author being added or removed.
Only in exceptional circumstances will the Editor consider the addition, deletion or rearrangement of
authors after the manuscript has been accepted. While the Editor considers the request, publication
of the manuscript will be suspended. If the manuscript has already been published in an online issue,
any requests approved by the Editor will result in a corrigendum.
Reporting clinical trials
Randomized controlled trials should be presented according to the CONSORT guidelines. At manuscript
submission, authors must provide the CONSORT checklist accompanied by a flow diagram that
illustrates the progress of patients through the trial, including recruitment, enrollment, randomization,
withdrawal and completion, and a detailed description of the randomization procedure. The CONSORT
checklist and template flow diagram are available online.
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Article transfer service
This journal is part of our Article Transfer Service. This means that if the Editor feels your article is
more suitable in one of our other participating journals, then you may be asked to consider transferring
the article to one of those. If you agree, your article will be transferred automatically on your behalf
with no need to reformat. Please note that your article will be reviewed again by the new journal.
More information.
Copyright
Upon acceptance of an article, authors will be asked to complete a 'Journal Publishing Agreement' (see
more information on this). An e-mail will be sent to the corresponding author confirming receipt of
the manuscript together with a 'Journal Publishing Agreement' form or a link to the online version
of this agreement.
Subscribers may reproduce tables of contents or prepare lists of articles including abstracts for internal
circulation within their institutions. Permission of the Publisher is required for resale or distribution
outside the institution and for all other derivative works, including compilations and translations. If
excerpts from other copyrighted works are included, the author(s) must obtain written permission
from the copyright owners and credit the source(s) in the article. Elsevier has preprinted forms for
use by authors in these cases.
For gold open access articles: Upon acceptance of an article, authors will be asked to complete an
'Exclusive License Agreement' (more information). Permitted third party reuse of gold open access
articles is determined by the author's choice of user license.
Author rights
As an author you (or your employer or institution) have certain rights to reuse your work. More
information.
Elsevier supports responsible sharing
Find out how you can share your research published in Elsevier journals.
Role of the funding source
You are requested to identify who provided financial support for the conduct of the research and/or
preparation of the article and to briefly describe the role of the sponsor(s), if any, in study design; in
the collection, analysis and interpretation of data; in the writing of the report; and in the decision to
submit the article for publication. If the funding source(s) had no such involvement then this should
be stated.
Funding body agreements and policies
Elsevier has established a number of agreements with funding bodies which allow authors to comply
with their funder's open access policies. Some funding bodies will reimburse the author for the gold
open access publication fee. Details of existing agreements are available online.
Open access
This journal offers authors a choice in publishing their research:
Subscription
• Articles are made available to subscribers as well as developing countries and patient groups through
our universal access programs.
• No open access publication fee payable by authors.
• The Author is entitled to post the accepted manuscript in their institution's repository and make this
public after an embargo period (known as green Open Access). The published journal article cannot be
shared publicly, for example on ResearchGate or Academia.edu, to ensure the sustainability of peer-
reviewed research in journal publications. The embargo period for this journal can be found below.
Gold open access
• Articles are freely available to both subscribers and the wider public with permitted reuse.
• A gold open access publication fee is payable by authors or on their behalf, e.g. by their research
funder or institution.
Regardless of how you choose to publish your article, the journal will apply the same peer review
criteria and acceptance standards.
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For gold open access articles, permitted third party (re)use is defined by the following Creative
Commons user licenses:
Creative Commons Attribution (CC BY)
Lets others distribute and copy the article, create extracts, abstracts, and other revised versions,
adaptations or derivative works of or from an article (such as a translation), include in a collective
work (such as an anthology), text or data mine the article, even for commercial purposes, as long
as they credit the author(s), do not represent the author as endorsing their adaptation of the article,
and do not modify the article in such a way as to damage the author's honor or reputation.
Creative Commons Attribution-NonCommercial-NoDerivs (CC BY-NC-ND)
For non-commercial purposes, lets others distribute and copy the article, and to include in a collective
work (such as an anthology), as long as they credit the author(s) and provided they do not alter or
modify the article.
The gold open access publication fee for this journal is USD 2000, excluding taxes. Learn more about
Elsevier's pricing policy: https://www.elsevier.com/openaccesspricing.
Green open access
Authors can share their research in a variety of different ways and Elsevier has a number of
green open access options available. We recommend authors see our green open access page for
further information. Authors can also self-archive their manuscripts immediately and enable public
access from their institution's repository after an embargo period. This is the version that has been
accepted for publication and which typically includes author-incorporated changes suggested during
submission, peer review and in editor-author communications. Embargo period: For subscription
articles, an appropriate amount of time is needed for journals to deliver value to subscribing customers
before an article becomes freely available to the public. This is the embargo period and it begins from
the date the article is formally published online in its final and fully citable form. Find out more.
This journal has an embargo period of 24 months.
Language (usage and editing services)
Please write your text in good English (American or British usage is accepted, but not a mixture of
these). Authors who feel their English language manuscript may require editing to eliminate possible
grammatical or spelling errors and to conform to correct scientific English may wish to use the English
Language Editing service available from Elsevier's WebShop.
Informed consent and patient details
Studies on patients or volunteers require ethics committee approval and informed consent, which
should be documented in the paper. Appropriate consents, permissions and releases must be obtained
where an author wishes to include case details or other personal information or images of patients
and any other individuals in an Elsevier publication. Written consents must be retained by the author
and copies of the consents or evidence that such consents have been obtained must be provided to
Elsevier on request. For more information, please review the Elsevier Policy on the Use of Images or
Personal Information of Patients or other Individuals. Unless you have written permission from the
patient (or, where applicable, the next of kin), the personal details of any patient included in any
part of the article and in any supplementary materials (including all illustrations and videos) must
be removed before submission.
Submission
Our online submission system guides you stepwise through the process of entering your article
details and uploading your files. The system converts your article files to a single PDF file used in
the peer-review process. Editable files (e.g., Word, LaTeX) are required to typeset your article for
final publication. All correspondence, including notification of the Editor's decision and requests for
revision, is sent by e-mail.
Referees
Please submit the names and institutional e-mail addresses of several potential referees. For more
details, visit our Support site. Note that the editor retains the sole right to decide whether or not the
suggested reviewers are used.
PREPARATION
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Peer review
This journal operates a double blind review process. All contributions will be initially assessed by the
editor for suitability for the journal. Papers deemed suitable are then typically sent to a minimum of
two independent expert reviewers to assess the scientific quality of the paper. The Editor is responsible
for the final decision regarding acceptance or rejection of articles. The Editor's decision is final. More
information on types of peer review.
Use of word processing software
It is important that the file be saved in the native format of the word processor used. The text
should be in single-column format. Keep the layout of the text as simple as possible. Most formatting
codes will be removed and replaced on processing the article. In particular, do not use the word
processor's options to justify text or to hyphenate words. However, do use bold face, italics, subscripts,
superscripts etc. When preparing tables, if you are using a table grid, use only one grid for each
individual table and not a grid for each row. If no grid is used, use tabs, not spaces, to align columns.
The electronic text should be prepared in a way very similar to that of conventional manuscripts (see
also the Guide to Publishing with Elsevier). Note that source files of figures, tables and text graphics
will be required whether or not you embed your figures in the text. See also the section on Electronic
artwork.
To avoid unnecessary errors you are strongly advised to use the 'spell-check' and 'grammar-check'
functions of your word processor.
Article structure
Subdivision - unnumbered sections
Divide your article into clearly defined sections. Each subsection is given a brief heading. Each heading
should appear on its own separate line. Subsections should be used as much as possible when cross-
referencing text: refer to the subsection by heading as opposed to simply 'the text'.
Introduction
State the objectives of the work and provide an adequate background, avoiding a detailed literature
survey or a summary of the results.
Material and methods
Provide sufficient details to allow the work to be reproduced by an independent researcher. Methods
that are already published should be summarized, and indicated by a reference. If quoting directly
from a previously published method, use quotation marks and also cite the source. Any modifications
to existing methods should also be described.
Theory/calculation
A Theory section should extend, not repeat, the background to the article already dealt with in the
Introduction and lay the foundation for further work. In contrast, a Calculation section represents a
practical development from a theoretical basis.
Results
Results should be clear and concise.
Discussion
This should explore the significance of the results of the work, not repeat them. A combined Results
and Discussion section is often appropriate. Avoid extensive citations and discussion of published
literature.
Conclusions
The main conclusions of the study may be presented in a short Conclusions section, which may stand
alone or form a subsection of a Discussion or Results and Discussion section.
Appendices
If there is more than one appendix, they should be identified as A, B, etc. Formulae and equations in
appendices should be given separate numbering: Eq. (A.1), Eq. (A.2), etc.; in a subsequent appendix,
Eq. (B.1) and so on. Similarly for tables and figures: Table A.1; Fig. A.1, etc.
Essential title page information
• Title. Concise and informative. Titles are often used in information-retrieval systems. Avoid
abbreviations and formulae where possible.
• Author names and affiliations. Please clearly indicate the given name(s) and family name(s)
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The main burden is the time it will take to complete the survey. 
 
Are there any possible risks of taking part? 
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uncomfortable you are free to miss that question out or withdraw at any time. We do not expect 
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University of Edinburgh has also evaluated the methodology and given ethical approval. 
  
What should I do now if I want to take part?  
If you would like to take part in the study, please complete the survey that can be found at the 
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If you have any further questions about the study please contact the researcher, Lindsay-Jo 
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Section 1: Introduction 
1.1 Provide a brief critical review of relevant literature, which should clearly demonstrate the rationale 
and scientific justification for the research 
1000 – 1500 words 
Relevant to IRAS A12 
Prostate Cancer and Psychosocial Outcomes 
National Institute for Health and Care Excellence (NICE) guidelines (2014) indicate that for men, prostate 
cancer is the most common form of cancer, accounting for 26% of all cancer diagnosed in men. Over three 
quarters of men diagnosed with prostate cancer are over 65 (NICE, 2014).  
 
Psychological Distress 
Psychological Distress is defined differently throughout the cancer literature, however, the National 
Comprehensive Cancer Network (NCCN, 2013) definition is used most frequently: 
  
“Distress is a multifactorial unpleasant emotional experience of a psychological (cognitive, behavioural, 
emotional), social, and/or spiritual nature that may interfere with the ability to cope effectively with cancer, 
its physical symptoms and its treatment. Distress extends along a continuum, ranging from common 
normal feelings of vulnerability, sadness, and fears to problems that can become disabling, such as 
depression, anxiety, panic, social isolation, and existential and spiritual crisis” 
(pg7) 
 
Research shows that men with prostate cancer experience psychological distress (Balderson & Towell, 
2003). There are many stages in the cancer journey where psychological distress can be experienced for 
men with prostate cancer (e.g. diagnosis, decision making, treatment, recovery, survivorship) and research 
has shown that levels of distress experienced can fluctuate across these stages (Roth et al., 1998). This is 
proposed to be due to psychological demands on these individuals differing at each stage (Hsiao et al., 
2011). Some studies indicate that psychological distress is lower in prostate cancer when compared to 
other cancers (Venderbos et al., 2015), perhaps due to currently there being a higher survival rate for this 
form of cancer (Cancer Research UK Website, accessed 14/11/16). However, reviews looking at this have 
demonstrated mixed findings (Sharpley et al., 2008). The diversity of the findings might be explained by the 
way men display distress when they have prostate cancer. Mróz, Oliffe and Davison (2013) found that men 




with prostate cancer can cope with this by using emotionally detached responses such as stoicism. Wall et 
al., (2013) conducted a qualitative study of men’s experiences of the first year post their diagnosis of 
prostate cancer. The authors found that following a period of overt distress following the diagnosis, men 
used avoidance strategies to cope with further distress such as playing down the role of the psychological 
impact of having a diagnosis of prostate cancer. Blank & Bellizzi (2006) showed that the mixed results when 
looking at the levels of psychological distress in men who have survived prostate cancer may be due to the 
different coping styles used, with escapist coping style being negatively correlated with happiness and 
positive affect. Therefore, it may be that research is underestimating the level of distress associated with 
prostate cancer due to men using strategies to avoid their distress. 
 
Quality of Life 
Similarly, the findings related to Quality of Life (QoL) in individuals with prostate cancer seems to be mixed, 
fluctuating depending on their stage of cancer journey (Jeldres et al, 2015; Drummond et al, 2015). Katz 
(2007) found that men with PC’s QoL is affected, regardless of what type of active treatment they are on. 
Specifically, it was found that the effect of the PC treatment on a man’s sexual functioning had the most 
significant impact on their QoL (Katz, 2007). When looking across the whole cancer journey however, 
results are more mixed with certain stages of the prostate cancer journey being associated with lower QoL 
than others, for example, those who have undergone surgery tending to report lower QoL compared to 
those that are undergoing active surveillance (Jeldres et al, 2015). QoL is a broad concept, that often 
includes aspects related to physical health. Active treatment for PC is known to have large impact on 
physical health, for example, resulting in incontinence or sexual difficulties. Therefore, studies looking at 
QoL in individuals on active surveillance compared to active treatment are likely to conclude that overall 
QoL is higher in individuals on active surveillance (e.g. Jeldres et al., 2015), but this could be the physical 
impact of active treatment masking any psychological distress within the active surveillance population.  
 
Fear of Recurrence 
Individuals who have previously been diagnosed with prostate cancer can suffer fear that this cancer will 
return, and individuals currently diagnosed with prostate cancer experience similar fears that the cancer 
will return at some point in the future (Mehta et al., 2003). Fear of recurrence can be a burden to 
individuals with prostate cancer before and after treatment (Mehta et al., 2003). High fear of recurrence 
has also been shown to be related to both poorer QoL and higher psychological distress (Hart et al., 2008; 
Bellizzi et al., 2008). As with QoL and psychological distress in prostate cancer, the level of fear of 
recurrence can differ depending on which treatment that individuals is undergoing (Mehta et al., 2003).  





Acceptance and Commitment Therapy 
Acceptance and Commitment Therapy (ACT) suggests that psychological suffering is part of the human 
condition and attempts to control this can result in further suffering (Hayes, 2004). This may be done 
through experiential avoidance. Experiential avoidance describes attempts made to evade private internal 
events (thoughts, feelings etc.), even when doing so results in a life that is not in line with our values 
(Hayes et al., 1996). Trying to control internal events can result in a decrease in the number of behaviours 
willing to be carried out in case they bring up or result in the exact thoughts, feelings etc. that are being 
avoided (Hayes et al., 2006). ACT firstly aims to help increase an individual’s ability to stay with the distress 
that often accompanies living a life fully connected with values.  One of the ways ACT does this is by 
providing techniques to help people overcome this experiential avoidance. Secondly, it helps individuals to 
re-focus on what is important to them in their lives and how they can make changes to live a life that is in 
line with these things.  
 
Veehof et al., (2016) conducted a meta-analysis of RCTs of ACT for mental health of chronic pain patients 
and concluded that ACT is significantly better than other mindfulness based approaches. They also found 
that ACT was not significantly poorer than CBT, concluding ACT is a suitable alternative for CBT in a chronic 
pain population. A review by Hulbert-Williams and colleagues (2015) concluded that there is limited 
evidence to date in the use of ACT with cancer populations but there is sufficient to show that positive 
outcomes in relation to psychological distress are possible in cancer populations. Gundy et al., (2011) also 
concluded that ACT is worthy of further investigation in relation to the psychological aspects of cancer 
management. This highlights the importance of conducting research investigating the role of proposed 
mechanisms of action in ACT on mental health and wellbeing outcomes for individuals with prostate 
cancer. One of these proposed mechanisms of action is changes in psychological flexibility.  
 
Psychological Flexibility 
Psychological flexibility is an important part of psychological health and is defined by Kashdan (2010) as 
how well a person copes and adapts to varying psychological demands, applies mental resources flexibly, 
shifts their perspective depending on their context, and how well they balance competing demands on 
them. Kashdan (2010) also discusses psychological inflexibility in that it encompasses an individual who is 
at the other extreme of those elements of psychological flexibility and is characterised by an individual 
who is rigid, lacks sensitivity to context, and is inflexibility in their thinking. ACT proposed a model of 
psychopathology that consists of six core processes that are all interlinked. It is proposed that individually 




these six processes are related to psychological wellbeing and together are parts of the overall construct of 
“psychological inflexibility” (figure 1). These six processes are said to be one side of the coin, each having 
their own counterpart. These six counterparts are again interlinked with each other and feed in to an 
overall construct of “psychological flexibility” (figure 1) (Luoma et al., 2007). ACT theorises that individuals 
who are more psychologically flexible are better able to make values consistent behaviours in their own 
lives.  
 
Figure 1 – The ACT model of psychopathology, two sides of the coin, adapted from Luoma et al., (2007) 
 
Research shows that psychological flexibility is associated with increased QoL, lower psychological distress 
and greater wellbeing (Kashdan & Rottenberg, 2010). This finding has been replicated in clinical health 
populations (McCracken & Velleman, 2010). This association between psychological flexibility and 
psychological wellbeing is less well researched in cancer populations. Despite this, there is emerging 
evidence that targeting psychological flexibility when treating psychological distress in cancer patients 
might be more effective than other types of psychological interventions (Hulbert-Williams et al., 2016). As 
discussed above there is evidence that men use avoidance strategies to cope with the emotional impact of 
prostate cancer (Mróz, Oliffe and Davison 2013; Wall et al., 2013). This may result due to men with 
prostate cancer being psychologically inflexible. Given evidence that psychological inflexibility is associated 
with poorer mental health and wellbeing outcomes in general adult populations (Kashdan & Rottenberg, 
2010), it is important to establish the role (if any) of psychological inflexibility on mental health outcomes 
in men with prostate cancer.  
 
The measurement of psychological flexibility has often relied on the use of the Acceptance and Action 
Questionnaire (AAQ-II; Bond et al., 2011). Some authors have argued that the AAQ-II does not measure all 




facets of psychological flexibility, instead only measuring some of the six processes that make up the ACT 
model of psychopathology (figure 1) (Wolgast, 2014). There has also been some criticism of the AAQ-II that 
what it measures (ACT processes) overlaps with distress outcome variables (Wolgast, 2014). A new 
measure of psychological flexibility has recently been developed. The compACT (Francis, Dawson & 
Golijani-Moghaddam, 2016) is a 23-item measure which aims to measure psychological inflexibility. It is 
proposed that those that score highly on this measure are high in psychological inflexibility, and those that 
score low on this measure are high in psychological flexibility. The compACT has not been used to measure 
psychological flexibility in a cancer population previously. 
 
Rationale for Research 
As discussed above there is evidence that men with prostate cancer may use elements of the construct of 
psychological inflexibility in order to cope with the psychological distress of having prostate cancer, namely 
avoidance (Mróz, Oliffe and Davison 2013; Wall et al., 2013). There is evidence in the wider general adult 
population and clinical health populations that psychological inflexibility is associated with poorer mental 
health and wellbeing outcomes (e.g. Kashdan & Rottenberg, 2010; McCracken & Velleman, 2010). Despite 
limited research looking at the impact of psychological flexibility and inflexibility on cancer populations, 
recent papers have argued for a role of psychological flexibility on psychological distress in cancer patients 
(e.g. Hulbert-Williams et al., 2016). Therefore, this research aims to investigate further the role of 
psychological flexibility on psychological distress, quality of life and fear of recurrence in men with prostate 
cancer. This is with the goal of discovering whether psychological flexibility has a role in predicting 
psychological distress in cancer patients and therefore providing further evidence for the use of ACT in this 
population.  This research further aims to identify whether the compACT is a useful tool for measuring 
psychological flexibility in a cancer population. This is with the goal of providing researchers with evidence 
for using this as a tool for researching intervention studies in the future, and will also help service providers 
evaluate the service they offer individuals with prostate cancer.  
 
Section 2: Research Questions / Objectives 
2.1 What is the principal research question / objective? 
IRAS A10 
How well does psychological flexibility predict fear of cancer recurrence, QoL and Psychological Distress in 
individuals with prostate cancer once treatment type, age, length of time diagnosed, current or past 
psychological support for cancer related distress and country resident in are controlled for? 
2.2 What are the secondary research questions / objectives, if applicable? 
Keep these focused and concise, with a maximum of 5 research questions 
IRAS A11 








Section 3: Methodology 
3.1 Give a full summary of your design and methodology 
It should be clear exactly what will happen at each stage of the project 
IRAS A13 
Participants 
Participants will be men who have ever been diagnosed with prostate cancer. These individuals do not 
need to currently be in an active phase of their illness. 
 
Design 
This study aims to use a cross-sectional design to evaluate the association between psychological flexibility 
(as measured by the compACT), QoL (as measured by the PORPUS), psychological distress (as measured by 
the DASS) and fear of recurrence (as measured by the FRRS). Please see below for more details on the 
questionnaires proposed.  
 
Online Survey 
The data will be collected via an online survey. (Paper copies of the proposed measures will be made 
available to a small subset of participants if they so wish, please see protocol for more details). This survey 
will be hosted by the Bristol Online Survey Tool. This host has been chosen as it is supported by the 
University of Edinburgh and provides security features necessary to manage confidential data. The first 
page of this survey will be a title page that will contain information to assist the individual in providing 
informed consent, such as how their information will be used, what their participation involves and what 
to do if they no longer wish to continue with the survey. Individuals will be asked to tick a box to say that 
they agree to take part in the survey. If they click agree they will be taken to the rest of the survey which 
will contain the proposed questionnaires. If they click disagree they will be taken to the end of the survey, 




As the survey is completed online, it will be anonymous. Therefore, it will not be possible to retrieve an 
individual’s data if they wish for it to be withdrawn at a later stage. This will be explained to individuals in 
the participant information sheet as part of gaining informed consent.  




Patient’s becoming distressed during survey 
There is a possibility that individuals may become distressed during the survey. Despite none of the 
questionnaires asking specifically distressing information, there is a possibility that in answering questions 
about their cancer the individuals may become distressed. This will be discussed in the participant 
information sheet and individuals will have been made aware that they are entitled to drop out of the 
survey at any point by closing the browser window. Information will also be provided in the participant 
information sheet regarding what an individual should do if they find themselves becoming distressed 
including details for online support charities they can contact. These contacts will also be included in a final 
page of the survey, reminding individuals again who they can contact if they have become distressed 
during the survey. 
Individual’s taking part in the survey to get support 
It is possible that individuals who are currently struggling (for example with anxiety and depression) may 
take part in the survey to access support for this. The measures proposed are not diagnostic tools and this 
will be made clear in the participant information sheet. It will also be made clear that no feedback will be 
available to individuals about their specific scores. Information about charities that offer support to 
individuals with prostate cancer will be provided.  
 
Protocol 
Individuals who have been diagnosed with prostate cancer will be invited to take part in a survey. These 
individuals will be identified through the local Urology team in NHS Fife, through heads of Health 
Psychology in other boards and online via prostate cancer charities. Charities that have provisionally 
agreed to be involved in this study include; “Tackle Prostate Cancer” (UK based), “Men’s Cancer Alliance” 
(based in Ireland), “Prostate Cancer Foundation BC” (based in Canada), and Prostate Cancer Foundation of 
Australia. Individuals based in NHS Fife, will be contacted through the local prostate cancer nurse who will 
disseminate details of the study. This will include a participant information sheet with information about 
the study and contact details for the researcher to ask any questions they may have. Interested individuals 
will be provided with a link to the online survey. Individuals recruited from NHS Fife will also be able to 
complete paper copies of the questionnaire if they so wish, provided to them directly by the researcher.  
Individuals recruited from prostate cancer charities will be contacted by these charities either through 
established mailing lists or by placing a link to the survey on their websites. Details of the online survey will 
also be disseminated through other Clinical Health Psychology teams via the heads of these teams. The 
information contained in the participant information sheet will also be made available to these individuals 
either through the email or online. Individuals will again be provided with the researcher’s contact details 




and encouraged to take time to think about the survey and ask any questions they may have before taking 
part. Individuals who would like to take part will be directed to the online survey. 
 
Storage of Data 
All individuals taking part in the study will be anonymous and it will not be possible for the researcher to 
identify which data has come from which individual. Any hard copies of all questionnaires will be kept in 
locked cabinets within the locked psychology department on NHS premises. The anonymised data 
gathered through Bristol Online Survey tool along with that gathered through the NHS will be held by the 
University of Edinburgh. This data will be kept for a minimum of ten years before being deleted. Data will 
be downloaded into an Excel database and stored in a limited access folder on the networked area of the 
NHS Fife server which is backed up daily. No identifiable data will be kept on. Following completion of the 
research, all electronic data will be deleted. 
3.2 List the principal inclusion and exclusion criteria 
IRAS A17-1 and IRAS A17-2 
Inclusion: 
Men who have been diagnosed with prostate cancer at any point in their life 
Exclusion: 
Individuals with any other type of cancer 
3.3 How will data be collected? 
If quantitative, list proposed measures and justify the use of these measures. If qualitative, explain how 
data will be collected, giving reasonable detail (don’t just say “by interviews”.) 
Data will be collected via an online survey. This survey will contain generic questions to gather relevant 
demographic information including what treatment they are undertaking, how long since they were first 
diagnosed with prostate cancer, their age, whether they have previously or are currently receiving any 
formal support for their cancer related distress and what country they are resident in. Questionnaires 
measuring the following constructs will also be used: 
 
Psychological Flexibility 
This will be measured with the compACT (Francis, Dawson & Golijani-Moghaddam, 2016). This is a newly 
developed measure, which has demonstrated that it has a stable three factor structure (mapping onto the 
ACT model of psychopathology) and good internal consistency (Francis, Dawson & Golijani-Moghaddam, 
2016).  
The AAQ-II (Acceptance and Action Questionnaire-2nd version) (Bond et al., 2011) will also be used to 
measure psychological flexibility in order to assess how the compACT relates to this older, more validated 
measure of psychological flexibility. The AAQ-II has demonstrated good reliability with a mean alpha 
coefficient of .84 and adequate discriminant validity (Bond et al., 2011). This has also been used previously 




as a measure of psychological flexibility in clinical populations (Kortte, 2009). 
 
QoL 
This will be measured using the PORPUS (Patient Orientated Prostate Utility Scale) (Krahn et al, 2000). A 
review of measures used to assess QoL in individuals with prostate cancer highlighted four measures that 
were high quality, one of which was the PORPUS (Schmidt et al., 2014). The PORPUS was the only one of 
these four designed for use by individuals with prostate cancer at all stages of the disease (the other three 
being designed for use in early stage only). Test–retest reliability for the PORPUS as a psychometric 
instrument ranged from 0.79 to 0.81 and construct validity has been demonstrated (Ritvo et al., 2005). The 
PORPUS is free to use and is reasonably short at ten items long. 
 
Psychological Distress  
Psychological Distress will be measured using the DASS-21 (Depression Anxiety Stress Scales – 21 item) 
(Lovibond & Lovibond, 1995). This measures depression, anxiety and tension or stress. The original DASS 
was 42 items, however a short form version containing 21 items has also been developed and 
demonstrated to have good internal consistency (.94 for the depression subscale, .87 for the anxiety 
subscale and .91 for the stress subscale) and concurrent validity with other measures of distress (Anthony 
et al., 1998). The DASS-21 has been shown to validly measure all three aspects, whilst also providing an 
overall measure of psychological distress (Henry & Crawford, 2005). This more recent study also 
demonstrated the reliability of the overall scale to be .93 with the reliability for each of the subscales being 
.88 for depression, .82 for anxiety, and .90 for stress (Henry & Crawford, 2005). 
 
Fear of Recurrence 
This will be measured by a new scale Fear of Recurrence Scale (FoRS) developed by Ozakinci et al., (in 
preparation; as cited in Simard et al., 2013). The FoRS was used in a study by Rogers et al., (2010) which 
demonstrates the reliability for this scale using Cronbach’s alpha as 0.90 (Rogers et al., 2010). 
 
Section 4: Sample Size 
4.1 What sample size is needed for the research and how did you determine this? 
For quantitative projects, outline the relevant Power calculations and the rationale for assuming given 
effect sizes. For qualitative projects, outline your reasoning for assuming that this sample size will be 
sufficient to address the study’s aims 
IRAS A59 and IRAS A60 




Sample size was calculated using the G*Power programme. Due to the lack of research in this area, effect 
size was estimated to be medium (f=0.15) and power was set at 0.80. Alpha level was set at 0.05. This 
research will establish how well six predictors (psychological flexibility, treatment type, time since 
diagnosed, age, current or past psychological support for cancer related distress and country resident in) 
affect three different outcome variables (quality of life, psychological distress and fear of recurrence). 
Therefore, for a multiple regression with six predictors the total sample size required will be 98.  
4.2 Outline reasons for your confidence in being able to achieve a sample of at least this size 
Give details of size of known available sample(s), percentage of this type of sample that typically 
participate in such studies, opinions of relevant individuals working in that area 
As this is an online survey, individuals can be recruited from any English-speaking country. In one year in 
the UK as many as 34,335 individuals were diagnosed with prostate cancer (NICE, 2014). Therefore, there is 
a large pool of individuals to draw from. To access these individuals, the researcher will recruit from 
relevant cancer charities and preliminary interest from five cancer charities around the world regarding 
sending the survey to their members or putting a link to their survey on their website has already been 
garnered. Participants will also be recruited from NHS Fife directly where an active prostate cancer support 
group which have been amenable to taking part in research in the past is located. The local Urology Team 
are confident that a large proportion of the recruitment can take place within NHS Fife, for example, 
previously a piece of research conducted with a subset of individuals with prostate cancer in NHS Fife 
succeeded in recruiting over fifty individuals to this study. On discussion with academic supervisor, similar 
online survey research conducted in other clinical health populations have succeeded in recruiting 
sufficient individuals using relevant charities to disseminate information about the survey. 
 
Section 5: Analysis 
5.1 Describe the methods of analysis (statistical or other appropriate methods, e.g. for qualitative 
methods) by which the data will be evaluated to meet the study objectives 
IRAS A62 
The data will be analysed using SPSS. Relationships between each of the constructs will be analysed via 
correlation. Hierarchical multiple regression will be used to assess how much variance (how strong of a 
predictor) psychological flexibility accounts for in the outcomes of Qol, Psychological Distress or Fear of 
Recurrence when controlling for key demographic variables. 
 
Section 6: Project Management / Timetable 
6.1 Outline a timetable for completion of key stages of the project 
E.g. ethics submission, start and end of data collection, data analysis, completion of systematic review 
• Proposal agreed/not agreed and changes made Nov – Dec 16 
• Submit ethics form Dec 16 




• Ethics complete Jan/Feb 17 
• Survey preparation Dec 16 – Jan 16 
• Survey piloted with non-cancer population Feb 17 
• Survey live Mar 17 – Sept 17 
• Write Up: 
o Intro Feb 17 – Jun 17 (1st draft May 17) 
o Methods May 17 – Aug 17 (1st draft Jul 17) 
o Results Oct 17 – Dec 17 (1st draft Nov 17) 
o Discussion Jan 18 – Feb 18 
o First Full Draft Mar 18 
o Second Full Draft Apr 18 
o Submit May 18 
• Systematic Review Mar 17 – Sept 17 
 
 
Section 7: Management of Risks to Project 
7.1 Summarise the main potential risks to your study, the perceived likelihood of occurrence of these 
risks and any steps you will or have taken to reduce these risks. Outline how you will respond to 
identified risks if they should occur 
Sufficient numbers not recruited from NHS Fife 
As discussed, despite the opinion of the Urology Oncology team that it will be possible to recruit a large 
proportion of the numbers required from NHS Fife directly there is a risk that sufficient numbers will not 
be recruited. To ameliorate this risk, it is proposed that recruitment will be opened out to the whole of the 
UK and other English speaking countries. This will provide a very large pool of individuals from which to 
collect data from. 
 
Life Events 
It is likely that life events will occur throughout the research period that may impact on the research. The 
timescale proposed provides a generous amount of time for each aspect of the research, allowing some 
“wiggle room” for minor life events. The burden of written work has also been spread out, meaning that 
the pressure from these will be spread over the years the research is proposed to take place over.  
 
Time 
As this is a project that has changed from the original research proposed, there is now have less time than 




previously planned. However, this is a simpler project than the original idea that is achievable despite the 
reduced timescale now available. 
 
Participants becoming distressed whilst completing the survey 
Please see “ethical considerations” in the methodology section, where this risk has been previously 
addressed.  
 
Section 8: Knowledge Exchange 
8.1 How do you intend to report and disseminate the results of the study? 
IRAS A51 
Initially, an open evening will be arranged where the results from this study will be presented and 
questions or comments discussed. Interested parties will be invited to this including NHS staff, patients and 
third sector organisations. 
 
The NHS Fife Psychology Department hold a conference every two years, and the results from this study 
will be presented at this conference. The results will be fed back to the Health Psychology team and wider 
teams where possible and as appropriate. 
 
This study aims to be published in the Journal of Contextual Behavioural Science. The results will also be 
made available to members of the Association for Contextual and Behavioural Science by publishing them 
on their website. 
 
Finally, submissions to any relevant conferences that become available will be applied for following 
completion of the project. 
8.2 What are the anticipated benefits or implications of the project? 
E.g. If this is an NHS project, in what way(s) is the project intended to benefit the NHS? 
Current measures of psychological flexibility have been criticised, with new measures now developed to try 
to address these criticisms. This research will further evaluate the usefulness of these measures which will 
help to provide more accurate measures of psychological flexibility to assess ACT interventions in the 
future.  
 
This research will also evaluate how psychological flexibility links to other constructs relevant to individuals 
with prostate cancer. This may help inform future treatments for psychological distress in individuals with 
prostate cancer. There is a current need, identified by the Urology Oncology team regarding this 
population of patients. It is reported that psychological distress of individuals with prostate cancer is 




impacting on their service with regards to extra phone calls, examinations and appointments for these 
individuals. Therefore, if more targeted interventions can be provided for this population, this may 
improve the service for individuals with prostate cancer and ultimately save the service money. 
8.3 Are the any potential costs for the project? 
Outline any potential financial costs to the project, including the justification for the costs (why are these 
necessary for the research project?) and how funding will be obtained for these costs (how will they be 
met?) Please separate these into potential costs for the University and potential costs for your NHS Board 
and note that you should ask your NHS Board to meet stationery, printing, postage and travel costs. 
NHS Board 
The NHS board will cover costs for printing, stationery and postage required for gathering data. I plan to 
attend ACT training and will request CPD time, but will fund the training myself. 
 
University costs 
I do not foresee any costs for the University over and above the cost of time from input from my academic 
supervisor. 
 
Section 9: Any Other Relevant Information 
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